Processing 00000000.tx.1: Biologically Active Estrogen Receptor-: Evidence from in Vivo Autoradiographic Studies with Estrogen Receptor -Knockout Mice Paul J. 

Phrase: "Biologically Active Estrogen Receptor-"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   861   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "Evidence from in Vivo Autoradiographic Studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]

Phrase: "with Estrogen Receptor -Knockout Mice Paul J."
Processing 00000000.tx.2: Shughrue, Malcolm V. 

Phrase: "Shughrue,"

Phrase: "Malcolm V."
Processing 00000000.tx.3: Lane and Istvan Merchenthaler Womens Health Research Institute, Wyeth-Ayerst Research, Radnor, Pennsylvania 19087 Address all correspondence and requests for reprints to: Dr. 

Phrase: "Lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "Istvan Merchenthaler Womens Health Research Institute,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0035172:Research Institute [Organization]
   827   C0080339:Womens Health [Biomedical Occupation or Discipline]
   799   C0018684:Health [Idea or Concept]
   799   C0021622:institute [Organization]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1272753:Institute [Idea or Concept]

Phrase: "Wyeth-Ayerst Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   734   C0331933:Wyeth-Ayerst [Health Care Related Organization]

Phrase: "Radnor,"

Phrase: "Pennsylvania 19087"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030853:Pennsylvania [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.4: Paul J. 

Phrase: "Paul J."
Processing 00000000.tx.5: Shughrue, Womens Health Research Institute, Wyeth-Ayerst Research, 145 King of Prussia Road, Radnor, Pennsylvania 19087. 

Phrase: "Shughrue,"

Phrase: "Womens Health Research Institute,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0035172:Research Institute [Organization]
   861   C0080339:Womens Health [Biomedical Occupation or Discipline]
   812   C0018684:Health [Idea or Concept]
   812   C0021622:institute [Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "Wyeth-Ayerst Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   734   C0331933:Wyeth-Ayerst [Health Care Related Organization]

Phrase: "145 King of Prussia Road,"

Phrase: "Radnor,"

Phrase: "Pennsylvania 19087."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030853:Pennsylvania [Geographic Area]
Processing 00000000.tx.6: E-mail: shughrp{at}war.wyeth.com  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  Estrogen receptor- (ER) messenger RNA (mRNA) has been detected in the brain of wild-type and estrogen receptor- knockout (ERKO) mice. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "shughrp{at}war.wyeth.com  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Estrogen receptor- (ER) messenger RNA (mRNA)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0335218:Messenger [Professional or Occupational Group]

Phrase: "has"

Phrase: "been"

Phrase: "detected in the brain of wild-type"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0332307:Type [Qualitative Concept]
   748   C0442726:Detected [Finding]
   748   C0445392:Wild [Intellectual Product]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "estrogen receptor- knockout (ERKO) mice."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   861   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0206745:Knock-out Mice [Mammal]
   861   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   861   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0560617:knock out [Injury or Poisoning]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1522225:Knock-out [Experimental Model of Disease]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.7: The present study used in vivo autoradiography to evaluate the binding of 125I-estrogen, a compound with a similar affinity for both ERs to ascertain whether ER mRNA is translated into biologically active receptor. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in vivo autoradiography to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0004400:Autoradiography [Laboratory Procedure]
   712 E C2986957:Autoradiograph [Manufactured Object]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the binding of 125I-estrogen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "a compound with a similar affinity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0044729:a compound [Pharmacologic Substance,Steroid]
   790   C0211574:a compound [Organic Chemical,Pharmacologic Substance]
   753   C0205198:Compound [Qualitative Concept]
   753   C1706082:Compound [Chemical]

Phrase: "for both ERs to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704489:ERS [Clinical Attribute]
   861   C2931783:ERS [Disease or Syndrome]

Phrase: "ascertain"

Phrase: "whether"

Phrase: "ER mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0335218:Messenger [Professional or Occupational Group]

Phrase: "is"

Phrase: "translated into biologically active receptor."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0040710:translated [Occupational Activity]
   760   C0205177:Active [Functional Concept]
   760   C0205460:Biologically [Qualitative Concept]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.8: Mice were injected with 125I-estrogen, and sections were mounted on slides and opposed to emulsion. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "injected with 125I-estrogen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   770   C2936882:Estrogen [Pharmacologic Substance]
   737   C1720154:Inject [Functional Concept]

Phrase: "and"

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "mounted on slides"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444330:slides [Research Device]
   790   C0449878:mounted [Finding]
   756 E C0181909:Mount [Medical Device]
   756 E C1705201:Slide [Manufactured Object]

Phrase: "and"

Phrase: "opposed to emulsion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014020:Emulsion [Chemical Viewed Structurally]
   790   C0259862:Emulsion [Biomedical or Dental Material]
Processing 00000000.tx.9: After exposure, labeled cells were seen in ERKO brain regions where ER is expressed (preoptic and paraventricular nuclei of the hypothalamus; bed nucleus of the stria terminalis; amygdala; entorhinal cortex; and dorsal raphe). 

Phrase: "After exposure,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "labeled cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seen in ERKO brain regions where ER"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   760   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1273723:brain regions [Body Location or Region]
   760   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   760   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0006104:Brain [Body Part, Organ, or Organ Component]
   739   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   739   C0205397:Seen [Qualitative Concept]
   739   C0560617:knock out [Injury or Poisoning]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C1269537:Brain [Body Part, Organ, or Organ Component]
   739   C1522225:Knock-out [Experimental Model of Disease]
   739   C2936882:Estrogen [Pharmacologic Substance]
   706   C0017446:Region [Geographic Area]
   706 E C0042789:see [Organism Function]
   706   C0205147:Region [Spatial Concept]
   706 E C1947903:See [Activity]

Phrase: "is"

Phrase: "expressed"

Phrase: "(preoptic"

Phrase: "and"

Phrase: "paraventricular nuclei of the hypothalamus"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   888   C0030532:Paraventricular nucleus of hypothalamus [Body Part, Organ, or Organ Component]
       E   Paraventricular Nucleus
   833   C2337556:Nucleus of hypothalamus [Body Part, Organ, or Organ Component]
   806   C0175253:Paraventricular nuclei [Body Part, Organ, or Organ Component]
   773 E C1289558:Paraventricular nucleus [Body Location or Region]
   726   C0007610:Nucleus [Cell Component]

Phrase: "; bed nucleus of the stria terminalis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0228365:Bed Nucleus of Stria Terminalis [Body Part, Organ, or Organ Component]
           Nucleus of Stria Terminalis
           Stria terminalis nucleus
   753   C0004916:Bed [Manufactured Object]
   753   C0007610:Nucleus [Cell Component]
   753   C0596170:BED [Mental or Behavioral Dysfunction]

Phrase: "; amygdala"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002708:Amygdala [Body Part, Organ, or Organ Component]

Phrase: "; entorhinal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175196:Entorhinal Cortex [Body Part, Organ, or Organ Component]
  1000   C1289526:Entorhinal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: ";"

Phrase: "and"

Phrase: "dorsal raphe"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034671:RAPHE [Body Part, Organ, or Organ Component]
   861   C0205095:Dorsal [Spatial Concept]
   861   C0504074:Raphe [Body Space or Junction]

Phrase: ")."
Processing 00000000.tx.10: Competition studies with 17-estradiol eliminated binding in the ERKO brain, whereas 16IE2, an ER selective agonist and dihydrotestosterone had no effect. 

Phrase: "Competition studies with 17-estradiol"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0679932:competition [Social Behavior]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "binding in the ERKO brain,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1149369:estrogen receptor binding [Molecular Function]
   774   C0597358:Receptor Binding [Molecular Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "whereas"

Phrase: "16IE2,"

Phrase: "an ER selective agonist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2987634:Agonist [Pharmacologic Substance]

Phrase: "and"

Phrase: "dihydrotestosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038148:Dihydrotestosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "had"

Phrase: "no effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.11: In contrast, competition studies with 16IE2 in wild-type mice eliminated 125I-estrogen binding to ER and resulted in a pattern of residual binding comparable to that seen in the ERKO brain. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "competition studies with 16IE2"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0679932:competition [Social Behavior]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "in wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "125I-estrogen binding to ER"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C1149369:estrogen receptor binding [Molecular Function]
   783   C0597358:Receptor Binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "resulted in a pattern of residual binding"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C1523331:pattern binding [Molecular Function]
   748   C0243122:binding [Functional Concept]
   748   C0449774:Pattern [Spatial Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1609982:Residual [Qualitative Concept]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "comparable to that"

Phrase: "seen in the ERKO brain."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   778   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   748   C0205397:Seen [Qualitative Concept]
   748   C0560617:knock out [Injury or Poisoning]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1522225:Knock-out [Experimental Model of Disease]
   748   C2936882:Estrogen [Pharmacologic Substance]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]
Processing 00000000.tx.12: The results demonstrate that residual estrogen binding sites are present in regions of the ERKO brain where ER is expressed, brain regions that were also seen after eliminating binding to ER in wild-type mice. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that residual estrogen binding sites"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0005456:Binding Sites [Receptor]
   827 E C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Sites [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "present in regions of the ERKO brain where ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0150312:Present [Quantitative Concept]
   736   C0449450:Present [Idea or Concept]

Phrase: "is"

Phrase: "expressed"

Phrase: ","

Phrase: "brain regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C1273723:brain regions [Body Location or Region]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "also"

Phrase: "seen after eliminating binding"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205397:Seen [Qualitative Concept]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "to ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "in wild-type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.13: These data provide the first evidence that ER mRNA is translated into a biologically active protein in the rodent brain.  

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the first evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that ER mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0335218:Messenger [Professional or Occupational Group]

Phrase: "is"

Phrase: "translated into a biologically active protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0040710:translated [Occupational Activity]
   753   C0205177:Active [Functional Concept]
   753   C0205460:Biologically [Qualitative Concept]

Phrase: "in the rodent brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.14: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  ESTROGEN modulates the activity of specific neuronal populations in the brain and thereby governs an array of physiological parameters important for animal procreation and survival. 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "ESTROGEN"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the activity of specific neuronal populations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "thereby"

Phrase: "governs"

Phrase: "an array of physiological parameters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510941:Array [Spatial Concept]

Phrase: "important for animal procreation"

Phrase: "and"

Phrase: "survival."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]
Processing 00000000.tx.15: Numerous studies have demonstrated that estrogen action in the hypothalamus is critical for initiating reproductive behaviors and regulating GnRH release from the median eminence (1, 2, 3, 4). 

Phrase: "Numerous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that estrogen action in the hypothalamus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441472:Action [Functional Concept]
   753   C3266814:Action [Activity]

Phrase: "is"

Phrase: "critical for initiating reproductive behaviors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511545:Critical [Qualitative Concept]

Phrase: "and"

Phrase: "regulating"

Phrase: "GnRH release from the median eminence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.16: Additional studies have revealed that estrogen also regulates neurotransmitter production and release, enzyme activity, membrane potentials, dendritic arborization, synaptogenesis as well as other events in the rodent brain (4, 5, 6). 

Phrase: "Additional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that estrogen also"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "regulates"

Phrase: "neurotransmitter production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "release,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "enzyme activity,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0243102:enzyme activity [Molecular Function]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "membrane potentials,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0025251:Membrane Potentials [Cell Function]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   861   C3245505:potentials [Qualitative Concept]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "dendritic arborization,"

Phrase: "synaptogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597545:synaptogenesis [Organ or Tissue Function]

Phrase: "as well as"

Phrase: "other events in the rodent brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C2698908:OTHER EVENT [Event]
   753   C0441471:Events [Event]
   753   C3541888:Events [Classification]

Phrase: "(4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.17: Because some of the actions of estrogen occurred in regions that lacked the classical estrogen receptor (ER), it was thought that these actions were mediated through a putative membrane receptor, activation of second messenger systems, or through interneuronal connections (4, 7, 8). 

Phrase: "Because"

Phrase: "some of the actions of estrogen"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   753   C0205392:Some [Quantitative Concept]
   753   C0441472:actions [Functional Concept]
   753   C2936882:Estrogen [Pharmacologic Substance]
   753   C3540770:Some [Intellectual Product]
   719 E C3266814:Action [Activity]

Phrase: "occurred in regions"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C1709305:Occurred [Activity]
   756   C0017446:Region [Geographic Area]
   756   C0205147:Region [Spatial Concept]
   756 E C2745955:OCCUR [Temporal Concept]
   706 E C0205276:Regional [Spatial Concept]
   706 E C1947913:Regional [Spatial Concept]

Phrase: "that"

Phrase: "lacked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0332268:lack [Qualitative Concept]

Phrase: "the classical estrogen receptor"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "was"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "that"

Phrase: "these actions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441472:actions [Functional Concept]
   966 E C3266814:Action [Activity]

Phrase: "were"

Phrase: "mediated through a putative membrane receptor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0230664:Membrane receptor [Receptor]
   753   C0025255:Membrane [Tissue]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0596901:Membrane [Cell Component]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1706182:Membrane [Manufactured Object]

Phrase: "activation of second messenger systems,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "or through interneuronal connections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449379:connections [Intellectual Product]

Phrase: "(4,"

Phrase: "7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.18: The recent isolation of a second nuclear estrogen receptor (ER; 9, 10) and localization in brain (11) has provided new sites for estrogen action. 

Phrase: "The recent isolation of a second nuclear estrogen receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0204727:Isolation [Therapeutic or Preventive Procedure]
   742   C0205409:Isolation [Functional Concept]
   742   C0220862:isolation [Laboratory Procedure]

Phrase: "(ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "; 9,"

Phrase: "10"

Phrase: ")"

Phrase: "and"

Phrase: "localization in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0475264:Localisation [Functional Concept]
   790   C1744691:localisation [Biologic Function]

Phrase: "(11"

Phrase: ")"

Phrase: "has"

Phrase: "provided new sites for estrogen action."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   783   C0581718:action sites [Intellectual Product]
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.19: In situ hybridization histochemical studies have detected ER messenger RNA (mRNA) in some rat brain regions where ER was seen, but also in regions, such as the olfactory bulb, cortex, paraventricular, and supraoptic hypothalamic nuclei where ER was sparse or absent (11). 

Phrase: "In situ hybridization histochemical studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0947630:studies [Laboratory Procedure]
   771 E C0557651:Study [Manufactured Object]
   771 E C2603343:Study [Research Activity]
   717   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "have"

Phrase: "detected ER messenger RNA (mRNA)"

Phrase: "in some rat brain regions where ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   827   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C2936882:Estrogen [Pharmacologic Substance]
   727 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: ","

Phrase: "but"

Phrase: "also in regions,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   756   C0017446:Region [Geographic Area]
   756   C0205147:Region [Spatial Concept]
   706 E C0205276:Regional [Spatial Concept]
   706 E C1947913:Regional [Spatial Concept]

Phrase: "such as the olfactory bulb,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0028936:Olfactory Bulb [Body Part, Organ, or Organ Component]
  1000   C1281094:Olfactory bulb [Body Part, Organ, or Organ Component]
   861   C0025148:Bulb [Body Part, Organ, or Organ Component]
   861   C0037361:olfactory [Organism Function]
   861   C0439826:Olfactory [Organism Function]
   861   C1449865:Bulb [Plant]
   861   C1947952:Bulb [Anatomical Structure]

Phrase: "cortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "paraventricular,"

Phrase: "and"

Phrase: "supraoptic hypothalamic nuclei where ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   827   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C2936882:Estrogen [Pharmacologic Substance]
   727 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "sparse"

Phrase: "or"

Phrase: "absent"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332197:Absent [Quantitative Concept]
  1000   C2699517:ABSENT [Finding]
   928 E C0424530:Absences [Finding]
   928 E C1689985:Absence [Anatomical Abnormality]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.20: This observation suggested that many of the actions of estrogen in regions previously thought to lack ER may be attributed to ER. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "many of the actions of estrogen"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   753   C0439064:Many [Quantitative Concept]
   753   C0441472:actions [Functional Concept]
   753   C0747726:many [Conceptual Entity]
   753   C2936882:Estrogen [Pharmacologic Substance]
   719 E C3266814:Action [Activity]

Phrase: "in regions previously"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "attributed to ER."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   833   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   833   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C2936882:Estrogen [Pharmacologic Substance]
   737   C0449234:Attribute [Idea or Concept]
   737   C1704772:Attribute [Conceptual Entity]
   737   C1882133:Attribute [Qualitative Concept]
Processing 00000000.tx.21: In an attempt to further understand the importance of ER in the rodent brain, we must first ascertain whether ER mRNA is translated into biologically active protein in vivo. 

Phrase: "In an attempt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the importance of ER"

Phrase: "in the rodent brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "we"

Phrase: "must"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "ascertain"

Phrase: "whether"

Phrase: "ER mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0335218:Messenger [Professional or Occupational Group]

Phrase: "is"

Phrase: "translated into biologically active protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0040710:translated [Occupational Activity]
   760   C0205177:Active [Functional Concept]
   760   C0205460:Biologically [Qualitative Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.22: The present studies used in vivo steroid autoradiography to evaluate the presence and distribution of estrogen binding sites in the wild-type and estrogen receptor- knockout (ERKO) mouse brain. 

Phrase: "The present studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in vivo steroid autoradiography to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0004400:Autoradiography [Laboratory Procedure]
   704 E C2986957:Autoradiograph [Manufactured Object]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "distribution of estrogen binding sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "in the wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "estrogen receptor- knockout"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0560617:knock out [Injury or Poisoning]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1522225:Knock-out [Experimental Model of Disease]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(ERKO) mouse brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1521713:Mouse Brain [Tissue]
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.23: A new radiolabeled ligand (125I-estrogen; 12), that binds equally to ER and ER, was used to evaluate the distribution of estrogen binding sites in the ERKO brain and compare these sites with the known distribution of ER mRNA (13). 

Phrase: "A new radiolabeled ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023688:Ligand [Chemical]

Phrase: "(125I-estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "; 12"

Phrase: ")"

Phrase: ","

Phrase: "that"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "equally to ER"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   833   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   833   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "and"

Phrase: "ER,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the distribution of estrogen binding sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "in the ERKO brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "these sites with the known distribution of ER mRNA (13"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   751   C0005456:RECEPTOR SITES [Receptor]
   751   C0034804:Estrogen receptor site [Amino Acid, Peptide, or Protein,Receptor]
   736   C0205145:Sites [Spatial Concept]
   734   C2945843:Site of [Qualitative Concept]
   703 E C1515974:Site [Body Location or Region]
   703 E C2825164:Site [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.24: In addition, an ER selective agonist was used as a competitor in these studies to demonstrate that the residual binding seen in the ERKO brain was due to ER. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "an ER selective agonist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2987634:Agonist [Pharmacologic Substance]

Phrase: "was"

Phrase: "used as a competitor"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "in these studies to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the residual binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "seen in the ERKO brain"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   778   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   748   C0205397:Seen [Qualitative Concept]
   748   C0560617:knock out [Injury or Poisoning]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1522225:Knock-out [Experimental Model of Disease]
   748   C2936882:Estrogen [Pharmacologic Substance]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]

Phrase: "was due to ER."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   806   C0678226:Due to [Functional Concept]
           due
   806   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   806   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1421478:WAS [Gene or Genome]
   760   C2936882:Estrogen [Pharmacologic Substance]
   760   C3146286:Due [Idea or Concept]
Processing 00000000.tx.25: Together, the results of these studies provide the first evidence that a biologically active ER protein is present in the brain of wild-type and ERKO mice.  

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the results of these studies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results studies [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the first evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "a biologically active ER protein"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   884   C0059672:estrogen receptor protein [Amino Acid, Peptide, or Protein,Receptor]
   840   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   840   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   840   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C2936882:Estrogen [Pharmacologic Substance]
   733 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "present in the brain of wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "ERKO mice."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   861   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0206745:Knock-out Mice [Mammal]
   861   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   861   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0560617:knock out [Injury or Poisoning]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1522225:Knock-out [Experimental Model of Disease]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.26: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  In vitro binding studies For in vitro binding assays (n = 4), the ligand binding domains of human ER or ER modified with a carboxyl-terminal flag-epitope were expressed in Escherichia coli BL21(DE3) by IPTG induction at 25 C for 2 h. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "In vitro binding studies For in vitro binding assays"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   767   C0681828:in vitro study [Research Activity]
           studies vitro
   742   C0947630:studies [Laboratory Procedure]
   708 E C0557651:Study [Manufactured Object]
   708 E C2603343:Study [Research Activity]

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the ligand binding domains of human ER"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   793   C0597358:receptor ligand binding [Molecular Function]
           Receptor Binding
   793   C1149369:estrogen receptor binding [Molecular Function]
   782   C1516971:Estrogen Binding Domain [Amino Acid Sequence]
   770   C1517880:Ligand Binding [Molecular Function]
   767   C0682969:Ligand Binding Domain [Amino Acid Sequence]
   767   C1621296:receptor ligand [Molecular Function]
   744   C0023688:Ligand [Chemical]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   711   C1880389:Domain [Functional Concept]
   711   C1883221:Domain [Conceptual Entity]
   711   C3541951:Domain [Intellectual Product]

Phrase: "or"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "modified with a carboxyl-terminal flag-epitope"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0003316:Epitope [Immunologic Factor]
   748   C0205088:Terminal [Temporal Concept]
   748   C0392747:Modified [Functional Concept]
   748   C0596260:Carboxyl [Organic Chemical]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C1708067:Flag [Functional Concept]

Phrase: "were"

Phrase: "expressed in Escherichia coli BL21"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0014834:Escherichia coli [Bacterium]
   760   C0014833:Escherichia [Bacterium]
   760   C0450615:BL21 [Body Location or Region]

Phrase: "(DE3"

Phrase: ")"

Phrase: "by IPTG induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205263:Induction [Functional Concept]
   861   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "at 25 C"

Phrase: "for 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.27: A crude lysate was prepared in 50 mM Tris-Cl, 150 mM NaCl (pH 7.4) using a French press, and insoluble material was removed by centrifugation. 

Phrase: "A crude lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881488:Lysate [Physical Object]

Phrase: "was"

Phrase: "prepared in 50 mM Tris-Cl,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   753   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   753   C0596019:Cl - [Element, Ion, or Isotope]
   753   C0814229:TRI [Intellectual Product]
   719   C1521827:Prepare [Functional Concept]

Phrase: "150 mM NaCl (pH 7.4"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   839   C2678549:PH-4 [Gene or Genome]
   827   C1882074:pH 7 [Qualitative Concept]
   799   C0020283:[pH] [Quantitative Concept]
   799   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]
   799   C1959973:% NaCl [Quantitative Concept]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a French press,"

Phrase: "and"

Phrase: "insoluble material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "was"

Phrase: "removed by centrifugation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0849355:Removed [Qualitative Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]
Processing 00000000.tx.28: The binding reactions were performed in EG&G Wallac (Gaithersburg, MD) high binding 96-well plates containing 2 nM [3H] 17-estradiol (New England Nuclear, Boston, MA), unlabeled compound and 1 g crude lysate in Dulbeccos PBS supplemented with 1 mM EDTA. 

Phrase: "The binding reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "performed in EG&G Wallac"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0013715:EG [Geographic Area]
   760   C0439267:g% [Quantitative Concept]
   760   C0884358:Performed [Functional Concept]
   760   C1705651:EG [Idea or Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Gaithersburg,"

Phrase: "MD) high binding 96-well"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0205170:Well [Qualitative Concept]
   804   C0205250:High [Qualitative Concept]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1299351:High [Qualitative Concept]
   804   C2700149:HIGH [Intellectual Product]
   804   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2 nM [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "] 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(New England Nuclear, Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006037:Boston [Geographic Area]

Phrase: "MA"

Phrase: ")"

Phrase: ","

Phrase: "unlabeled compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205198:Compound [Qualitative Concept]
   861   C1706082:Compound [Chemical]

Phrase: "and"

Phrase: "1 g crude lysate in Dulbeccos PBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1881488:Lysate [Physical Object]

Phrase: "supplemented with 1 mM EDTA."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1418486:MM-1 [Gene or Genome]
   760   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.29: After incubation at room temperature for 5 h, unbound material was removed by rinsing, and bound DPMs were determined by liquid scintillation counting. 

Phrase: "After incubation"

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "for 5 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "unbound material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "was"

Phrase: "removed by rinsing,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0849355:Removed [Qualitative Concept]
   790   C1882955:Rinsing [Activity]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "bound DPMs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0641798:DPMS [Organic Chemical]
   827 E C1512024:DPM [Intellectual Product]
   827 E C1634619:dpm [Quantitative Concept]

Phrase: "were"

Phrase: "determined by liquid scintillation counting."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0036406:Scintillation Counting [Laboratory Procedure]
   760   C0302908:Liquid [Substance]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1304698:Liquid [Finding]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1561501:Liquid NOS [Substance]
   726   C0750480:Count [Activity]
   726   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.30: Animals C57BL/6J x 129 ERKO mice (14) were genotyped using PCR analysis of tail samples to assess the presence of the neomycin resistance and/or ER mRNAs (15). 

Phrase: "Animals C57BL/6J x 129 ERKO mice"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   879   C0025921:Mice, C57BL [Mammal]
   842   C1520439:Mice, 129 [Mammal]
   829   C1421546:X RECEPTOR [Gene or Genome]
   807   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   807   C0206745:Knock-out Mice [Mammal]
   807   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   807   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]
   791   C0560617:knock out [Injury or Poisoning]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C1522225:Knock-out [Experimental Model of Disease]
   791   C2936882:Estrogen [Pharmacologic Substance]
   720 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(14"

Phrase: ")"

Phrase: "were"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PCR analysis of tail samples to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0200931:PCR analysis [Laboratory Procedure]
   767   C1303103:Sample analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0677874:pCR [Finding]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the presence of the neomycin resistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and/or"

Phrase: "ER mRNAs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   734   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.31: Pups exhibiting only the neomycin resistance mRNA were considered homozygous mice, whereas animals that express ER were wild types. 

Phrase: "Pups"

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the neomycin resistance mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0335218:Messenger [Professional or Occupational Group]

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "homozygous mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "whereas"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "that"

Phrase: "express"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "wild types."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Types [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   827 E C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.32: The ERKO and wild-type mice used in these studies were 28-day-old postnates. 

Phrase: "The ERKO"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0560617:knock out [Injury or Poisoning]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1522225:Knock-out [Experimental Model of Disease]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "used in these studies"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   802   C0869040:Use studies [Research Activity]
   770   C0947630:studies [Laboratory Procedure]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]
   737 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "28-day-old postnates."
Processing 00000000.tx.33: This age was selected because it allowed us to take advantage of the animals low body weight, using less radiolabeled ligand, while still obtaining information about the developed brain. 

Phrase: "This age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "because"

Phrase: "it"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "advantage of the animals low body weight,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "less radiolabeled ligand,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023688:Ligand [Chemical]

Phrase: "while"

Phrase: "still"

Phrase: "obtaining"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   966   C1301820:Obtain [Functional Concept]
   966   C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "information about the developed brain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1533716:Information [Idea or Concept]
Processing 00000000.tx.34: The studies described in this paper were reviewed and approved by the Wyeth-Ayerst Research, Animal Care and Use Committee. 

Phrase: "The studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "described in this paper"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030351:Paper [Manufactured Object]
   770   C1547566:Paper [Idea or Concept]
   770   C1552738:described [Idea or Concept]

Phrase: "were"

Phrase: "reviewed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0282443:reviewed [Intellectual Product]
  1000   C1709940:Reviewed [Qualitative Concept]
   966 E C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "approved by the Wyeth-Ayerst Research,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0331933:Wyeth-Ayerst [Health Care Related Organization]
   753   C0035168:research [Research Activity]
   753   C0205540:Approved [Qualitative Concept]
   753   C0242481:Research [Research Activity]
   753   C0331760:Ayerst [Health Care Related Organization]

Phrase: "Animal Care"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178478:animal care [Occupation or Discipline]
   861   C1947933:Care [Activity]

Phrase: "and"

Phrase: "Use Committee."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2699414:Committee [Group]
Processing 00000000.tx.35: In vivo binding studies On postnatal day 21, ERKO and wild-type mice were ovariectomized and weaned from their mothers. 

Phrase: "In vivo binding studies On postnatal day 21,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   776   C0681829:in vivo study [Research Activity]
           studies vivo
   750   C2826182:Study Day [Temporal Concept]
   744   C0947630:studies [Laboratory Procedure]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "ERKO"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0560617:knock out [Injury or Poisoning]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1522225:Knock-out [Experimental Model of Disease]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "were"

Phrase: "ovariectomized"

Phrase: "and"

Phrase: "weaned from their mothers."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026591:Mothers [Family Group]
   770   C0043084:weaned [Organism Function]
Processing 00000000.tx.36: Seven days after surgery, the ovariectomized mice were sc injected in the dorsal cervical region with 100 l of vehicle (50% DMSO, 40% PBS, and 10% ethanol; n = 5/group) or 250 g/kg BW of 17-estradiol (n = 2/group), 16-iodo-17-estradiol (16IE2; a gift from Dr. R. Hochberg, Yale University, New Haven, CT, see 16; n = 3/group), the androgen dihydrotestosterone (Sigma Chemical Co.; n = 1/group) or a synthetic progestin R5020 (NEN; n = 1/group). 

Phrase: "Seven days after surgery,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   816   C1710063:SEVEN-DAY [Intellectual Product]
   802   C0282046:Surgery, Day [Therapeutic or Preventive Procedure]
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "the ovariectomized mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "sc"

Phrase: "injected in the dorsal cervical region"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0556956:Cervical region [Body Location or Region]
   790   C0920882:Cervical region [Body Location or Region]
   783   C1456859:Dorsal region [Body Location or Region]
   753   C0017446:Region [Geographic Area]
   753   C0027530:Cervical [Body Location or Region]
   753   C0205064:Cervical [Spatial Concept]
   753   C0205095:Dorsal [Spatial Concept]
   753   C0205147:Region [Spatial Concept]
   719   C1720154:Inject [Functional Concept]

Phrase: "with 100 l"

Phrase: "of vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "(50% DMSO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012403:DMSO [Organic Chemical,Pharmacologic Substance]

Phrase: "40% PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720830:PBS [Disease or Syndrome]
   861   C1823521:PBS [Gene or Genome]

Phrase: "and"

Phrase: "10% ethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:Ethanol [Organic Chemical]

Phrase: "; n = 5/group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   734   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "or"

Phrase: "250 g/kg BW of 17-estradiol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0005910:BW [Organism Attribute]
   748   C0006041:BW [Geographic Area]
   748   C2986891:BW [Idea or Concept]

Phrase: "(n = 2/group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: ")"

Phrase: ","

Phrase: "16-iodo-17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   756 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   756 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(16IE2"

Phrase: ";"

Phrase: "a gift from Dr. R. Hochberg,"

Phrase: "Yale University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "New Haven,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205314:New [Temporal Concept]

Phrase: "CT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "16"

Phrase: "; n = 3/group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: ")"

Phrase: ","

Phrase: "the androgen dihydrotestosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038148:Dihydrotestosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(Sigma Chemical Co."

Phrase: "; n = 1/group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: ")"

Phrase: "or"

Phrase: "a synthetic progestin R5020"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0878080:R5020 [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(NEN"

Phrase: "; n = 1/group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: ")."
Processing 00000000.tx.37: Thirty minutes after the initial injection, mice where again injected with the same compound as well as 2 g/kg BW of 17-iodovinyl-11-methoxyestradiol (125I-estrogen; specific activity 2200 Ci/mM). 

Phrase: "Thirty minutes after the initial injection,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0439232:minute [Temporal Concept]
   753   C0700321:minute [Quantitative Concept]
   753   C0702093:/minute [Temporal Concept]
   753   C1282918:Minute [Quantitative Concept]
   753   C2347166:Minute [Quantitative Concept]

Phrase: "mice where again"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "injected with the same compound"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205198:Compound [Qualitative Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C1706082:Compound [Chemical]
   726   C1720154:Inject [Functional Concept]

Phrase: "as well as"

Phrase: "2 g/kg BW of 17-iodovinyl-11-methoxyestradiol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0005910:BW [Organism Attribute]
   742   C0006041:BW [Geographic Area]
   742   C2986891:BW [Idea or Concept]

Phrase: "(125I-estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "; specific activity 2200 Ci/mM"

Phrase: ")."
Processing 00000000.tx.38: The 125I-estrogen was obtain from the iodination (New England Nuclear custom iodination) of E-17-tributylstannyvinyl-11-methoxy estradiol (RAXL Enterprises, Inc., Newton, MA) as described previously (12). 

Phrase: "The 125I-estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "obtain from the iodination"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0430302:Iodination [Laboratory Procedure]
   770   C0542502:Iodination [Natural Phenomenon or Process]
   770   C1301820:Obtain [Functional Concept]
   770   C1706701:Obtain [Activity]
   715 E C1517378:Gain [Quantitative Concept]

Phrase: "(New England Nuclear custom iodination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0430302:Iodination [Laboratory Procedure]
   804   C0542502:Iodination [Natural Phenomenon or Process]

Phrase: ")"

Phrase: "of E-17-tributylstannyvinyl-11-methoxy estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   743 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   743 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(RAXL Enterprises,"

Phrase: "Inc.,"

Phrase: "Newton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0542569:newton [Quantitative Concept]

Phrase: "MA)"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.39: One hour after injection of 125I-estrogen, the brains were collected, frozen and 16 m coronal cryostat sections thaw-mounted onto gelatin-coated slides. 

Phrase: "One hour after injection of 125I-estrogen,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439227:Hour [Temporal Concept]
   748   C0564385:/hour [Quantitative Concept]

Phrase: "the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "frozen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016701:Frozen [Natural Phenomenon or Process]
  1000   C0677542:Frozen [Functional Concept]

Phrase: "and"

Phrase: "16 m coronal cryostat sections thaw-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1710378:Thaw [Laboratory Procedure]

Phrase: "mounted onto gelatin-coated slides."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   760   C0444330:slides [Research Device]
   760   C0449878:mounted [Finding]
   760   C1145617:Gelatin [Food]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0181909:Mount [Medical Device]
   726 E C0453946:Coat [Manufactured Object]
   726 E C1705201:Slide [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]
Processing 00000000.tx.40: Section-mounted slides were apposed to x-ray film (Eastman Kodak, Rochester, NY; BMR-1) for 16 h and then processed for emulsion coating (17). 

Phrase: "Section-mounted slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0444330:slides [Research Device]
   793 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "apposed to x-ray film"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0043303:X-Ray Film [Medical Device]
   806   C0034571:X-ray [Functional Concept]
   806   C0043299:X-ray, NOS [Diagnostic Procedure]
   806   C0043309:X-ray [Natural Phenomenon or Process]
   806   C1306645:X-ray [Diagnostic Procedure]
   806   C1962945:X-ray [Diagnostic Procedure]
   760   C0086296:Film [Manufactured Object]
   760   C0086894:ray [Fish]
   760   C0851346:ray [Natural Phenomenon or Process]
   760   C1561571:film [Biomedical or Dental Material]
   760   C1561572:film [Substance]
   760   C2314876:ray [Fish]

Phrase: "(Eastman Kodak,"

Phrase: "Rochester,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: "; BMR-1"

Phrase: ")"

Phrase: "for 16 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "processed for emulsion coating"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0014020:Emulsion [Chemical Viewed Structurally]
   770   C0259862:Emulsion [Biomedical or Dental Material]
   770   C1522240:Processed [Phenomenon or Process]
   770   C1522408:Coating [Qualitative Concept]
   770   C1704806:Coating [Biomedical or Dental Material]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.41: Briefly, section-mounted slides were washed for 5 min in 4 C PM buffer (3 mM MgCl2, 1 mM KH2PO4, pH 6.8), postfixed for 5 min in ice-cold 4% paraformaldehyde, washed 3 x 5 min in 4 C PMTX buffer (PM buffer containing 0.1% Triton X-100), washed 2 x 5 min in 4 C PM buffer, dipped in water, and allowed to dry at room temperature. 

Phrase: "Briefly,"

Phrase: "section-mounted slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0444330:slides [Research Device]
   793 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "washed for 5 min"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1548982:Washed [Idea or Concept]
   737 E C0441648:Wash [Activity]

Phrase: "in 4 C PM buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(3 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1 mM KH2PO4,"

Phrase: "pH 6.8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "postfixed for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "in ice-cold 4% paraformaldehyde,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "3 x 5 min in 4 C PMTX buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0702093:/min [Temporal Concept]

Phrase: "(PM buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "2 x 5 min in 4 C PM buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0702093:/min [Temporal Concept]

Phrase: "dipped in water,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1550678:Water [Inorganic Chemical]
   756   C3539618:DIP [Gene or Genome]
   718 E C0443350:Watery [Qualitative Concept]

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "dry at room temperature."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0011682:Dry [Natural Phenomenon or Process]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0205222:Dry [Qualitative Concept]
   770   C1512080:Dry [Qualitative Concept]
   770   C1547703:Room [Spatial Concept]
Processing 00000000.tx.42: The slides were then dipped in liquid nuclear emulsion (Kodak, NTB-2, diluted 1:1 with water), air dried and stored at 4 C in light-tight desiccator slide boxes. 

Phrase: "The slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "dipped in liquid nuclear emulsion"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0014020:Emulsion [Chemical Viewed Structurally]
   760   C0259862:Emulsion [Biomedical or Dental Material]
   760   C0302908:Liquid [Substance]
   760   C0521447:Nuclear [Spatial Concept]
   760   C1304698:Liquid [Finding]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1561501:Liquid NOS [Substance]
   726   C3539618:DIP [Gene or Genome]

Phrase: "(Kodak,"

Phrase: "NTB-2,"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1 with water"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1550678:Water [Inorganic Chemical]
   790   C2827734:1+ [Quantitative Concept]
   790   C2981698:1+ [Classification]
   718 E C0443350:Watery [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "air dried"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0001861:Air [Substance]
   861   C1512080:Dried [Qualitative Concept]
   861   C2827485:Dried [Body Substance]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   827 E C0011682:Dry [Natural Phenomenon or Process]
   827 E C0205222:Dry [Qualitative Concept]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "stored at 4 C in light-tight desiccator slide boxes."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   739   C0023693:Light [Natural Phenomenon or Process]
   739   C0179400:boxes [Manufactured Object]
   739   C0439816:Tight [Qualitative Concept]
   739   C0444330:Slide [Research Device]
   739   C0453911:tight [Manufactured Object]
   739   C1306462:Light [Functional Concept]
   739   C1638312:Boxes [Quantitative Concept]
   739   C1705201:Slide [Manufactured Object]
   739   C1881376:Light [Qualitative Concept]
   706 E C1533124:Box [Medical Device]
   706   C1698986:Store [Functional Concept]
Processing 00000000.tx.43: After 1030 days of exposure, the slides were developed, stained with cresyl violet and coverslipped. 

Phrase: "After 1030 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of exposure,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "the slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "developed"

Phrase: ","

Phrase: "stained with cresyl violet"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   865   C0056484:Cresyl violet stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           cresyl violet
   770   C0330463:Violet [Plant]
   770   C0678580:violet [Natural Phenomenon or Process]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "coverslipped."
Processing 00000000.tx.44: Brain autoradiograms were scanned at low magnification with a light microscope to determine the regional distribution of estrogen target cells in the forebrain regions of wild-type and ERKO mice. 

Phrase: "Brain autoradiograms"

Phrase: "were"

Phrase: "scanned at low magnification"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205251:low [Qualitative Concept]
   770   C0441633:scanned [Diagnostic Procedure]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]
   737 E C0034606:Scan [Diagnostic Procedure]
   737 E C2826292:SCAN [Finding]

Phrase: "with a light microscope to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0491970:Light Microscope [Medical Device]
   827   C0023693:Light [Natural Phenomenon or Process]
   827   C0181839:Microscope [Medical Device]
   827   C1306462:Light [Functional Concept]
   827   C1706379:Microscope [Medical Device]
   827   C1881376:Light [Qualitative Concept]

Phrase: "determine"

Phrase: "the regional distribution of estrogen target cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "in the forebrain regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "of wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "ERKO mice."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   861   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0206745:Knock-out Mice [Mammal]
   861   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   861   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0560617:knock out [Injury or Poisoning]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1522225:Knock-out [Experimental Model of Disease]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.45: Brain regions where ER mRNA is expressed were further evaluated to determine the relationship between the distribution of ER mRNA and the residual binding seen in the ERKO mice as well as the effect of competition with 17-estradiol, 16IE2, dihydrotestosterone, or R5020. 

Phrase: "Brain regions where ER mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   795   C0335218:Messenger [Professional or Occupational Group]

Phrase: "is"

Phrase: "expressed"

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the relationship between the distribution of ER mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0439849:Relationship [Qualitative Concept]
   739   C1705630:Relationship [Idea or Concept]
   739   C1706279:Relationship [Idea or Concept]
   739   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "the residual binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "seen in the ERKO mice"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   778   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C0206745:Knock-out Mice [Mammal]
   778   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   778   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0205397:Seen [Qualitative Concept]
   748   C0560617:knock out [Injury or Poisoning]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1522225:Knock-out [Experimental Model of Disease]
   748   C2936882:Estrogen [Pharmacologic Substance]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]

Phrase: "as well as"

Phrase: "the effect of competition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "with 17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "16IE2,"

Phrase: "dihydrotestosterone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038148:Dihydrotestosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "or"

Phrase: "R5020."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878080:R5020 [Hormone,Pharmacologic Substance,Steroid]
Processing 00000000.tx.46: In situ hybridization The distribution of ER mRNA was also evaluated in the ERKO mouse brain with in situ hybridization histochemistry as previously described (13). 

Phrase: "In situ hybridization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   901   C0444498:In situ [Spatial Concept]
   827   C0020202:Hybridisation [Genetic Function]
   827   C1300517:Hybridization [Laboratory Procedure]

Phrase: "The distribution of ER mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "also"

Phrase: "evaluated in the ERKO mouse brain"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   770   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0206745:Knock-Out Mouse [Mammal]
   770   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   770   C1521713:Mouse Brain [Tissue]
   770   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0220825:Evaluated [Functional Concept]
   744   C0560617:knock out [Injury or Poisoning]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1522225:Knock-out [Experimental Model of Disease]
   744   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "with in situ hybridization histochemistry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0019635:Histochemistry [Laboratory Procedure]
   756   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.47: Briefly, female ERKO mice were ovariectomized for 57 days, euthanized, and their brains collected and frozen on dry ice. 

Phrase: "Briefly,"

Phrase: "female ERKO mice"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   840   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C0206745:Knock-out Mice [Mammal]
   840   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   840   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   804   C0560617:knock out [Injury or Poisoning]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1522225:Knock-out [Experimental Model of Disease]
   804   C2936882:Estrogen [Pharmacologic Substance]
   733 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "ovariectomized for 57 days,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "euthanized"

Phrase: ","

Phrase: "and"

Phrase: "their brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "frozen on dry ice."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0013239:Dry Ice [Inorganic Chemical]
   770   C0011682:Dry [Natural Phenomenon or Process]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0020746:Ice [Inorganic Chemical]
   770   C0205222:Dry [Qualitative Concept]
   770   C0677542:Frozen [Functional Concept]
   770   C1512080:Dry [Qualitative Concept]
Processing 00000000.tx.48: Twenty micron coronal cryostat sections were mounted on gelatin-coated slides, processed for in situ hybridization, and hybridized with 200 l of an antisense or sense (control) 35S-labeled riboprobe (8 x 106 DPM/probe/slide) -50% formamide hybridization mixture containing a cocktail of two unique riboprobes for ER mRNA (ER 558 and ER 600; see Ref. 13). 

Phrase: "Twenty micron coronal cryostat sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   771   C0205155:Section [Spatial Concept]
   771   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   771   C1522472:Section [Substance]
   771   C1552923:Section [Quantitative Concept]
   771   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "mounted on gelatin-coated slides,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   760   C0444330:slides [Research Device]
   760   C0449878:mounted [Finding]
   760   C1145617:Gelatin [Food]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0181909:Mount [Medical Device]
   726 E C0453946:Coat [Manufactured Object]
   726 E C1705201:Slide [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "processed for in situ hybridization,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   806   C0444498:In situ [Spatial Concept]
   760   C0020202:Hybridisation [Genetic Function]
   760   C1300517:Hybridization [Laboratory Procedure]
   760   C1522240:Processed [Phenomenon or Process]
   726 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "hybridized with 200 l of an antisense"

Phrase: "or"

Phrase: "sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "35S-labeled riboprobe"

Phrase: "(8 x 106 DPM/probe/slide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0444330:Slide [Research Device]
   799   C1705201:Slide [Manufactured Object]

Phrase: ") -"

Phrase: "50% formamide hybridization mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439962:Mixture [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a cocktail of two unique riboprobes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678420:Cocktail [Food]

Phrase: "for ER mRNA (ER 558"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   818   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   818   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   818   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   818   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   795   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   795   C0335218:Messenger [Professional or Occupational Group]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C2936882:Estrogen [Pharmacologic Substance]
   724 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ER 600"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.49: The section-mounted slides were incubated overnight at 55 C in a humidified chamber, treated with RNase A, and stringently washed at 67 C in 0.1 x SSC to remove nonspecific label. 

Phrase: "The section-mounted slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0444330:slides [Research Device]
   793 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight at 55 C in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439583:Overnight [Temporal Concept]
   760   C0450382:55 [Intellectual Product]

Phrase: "a humidified chamber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "treated with RNase A,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "stringently"

Phrase: "washed at 67 C in 0.1 x SSC to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1548982:Washed [Idea or Concept]
   706 E C0441648:Wash [Activity]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "nonspecific label."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0181496:Label [Manufactured Object]
   861   C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.50: Slides were then dehydrated, apposed to x-ray film for 5 days, and dipped in NTB2 nuclear emulsion. 

Phrase: "Slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "dehydrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011175:Dehydrated [Disease or Syndrome]

Phrase: ","

Phrase: "apposed to x-ray film"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0043303:X-Ray Film [Medical Device]
   806   C0034571:X-ray [Functional Concept]
   806   C0043299:X-ray, NOS [Diagnostic Procedure]
   806   C0043309:X-ray [Natural Phenomenon or Process]
   806   C1306645:X-ray [Diagnostic Procedure]
   806   C1962945:X-ray [Diagnostic Procedure]
   760   C0086296:Film [Manufactured Object]
   760   C0086894:ray [Fish]
   760   C0851346:ray [Natural Phenomenon or Process]
   760   C1561571:film [Biomedical or Dental Material]
   760   C1561572:film [Substance]
   760   C2314876:ray [Fish]

Phrase: "for 5 days,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442466:5 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "dipped in NTB2 nuclear emulsion."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0014020:Emulsion [Chemical Viewed Structurally]
   760   C0259862:Emulsion [Biomedical or Dental Material]
   760   C0521447:Nuclear [Spatial Concept]
   726   C3539618:DIP [Gene or Genome]
Processing 00000000.tx.51: The slides were exposed for 24 weeks, photographically processed, stained in cresyl violet, and coverslipped.  

Phrase: "The slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "exposed for 24 weeks,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0332157:Exposed [Clinical Attribute]
   770   C0439230:weeks [Temporal Concept]
   737 E C0332174:/week [Temporal Concept]

Phrase: "photographically"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: ","

Phrase: "stained in cresyl violet,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   865   C0056484:Cresyl violet stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           cresyl violet
   770   C0330463:Violet [Plant]
   770   C0678580:violet [Natural Phenomenon or Process]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "coverslipped."
Processing 00000000.tx.52: Results Top Abstract Introduction Materials and Methods Results Discussion References  A requisite for evaluating the presence and biological activity of ER protein in the brain of wild-type and ERKO mice was the identification of a radiolabeled ligand that had the same binding affinity for both ERs. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A requisite for evaluating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514873:Requisite [Functional Concept]

Phrase: "the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "biological activity of ER protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   820   C1148776:estrogen receptor activity [Molecular Function]
   783   C1152633:receptor activity [Molecular Function]
   783   C1537044:protein activity [Molecular Function]
   753   C0005532:Biological [Biomedical Occupation or Discipline]
   753   C0205177:Activity [Functional Concept]
   753   C0205460:biological [Qualitative Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "ERKO mice"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   861   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0206745:Knock-out Mice [Mammal]
   861   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   861   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0560617:knock out [Injury or Poisoning]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1522225:Knock-out [Experimental Model of Disease]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "the identification of a radiolabeled ligand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "that"

Phrase: "had"

Phrase: "the same binding affinity for both ERs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510827:Affinity [Natural Phenomenon or Process]
Processing 00000000.tx.53: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.54: 1, early competition studies with 16-iodo-17-estradiol (16IE2) and [3H]17-estradiol on ER and ER revealed that 16IE2 was a very selective ER agonist, with an IC50 of 5.03 nM  1.33 (mean + SEM; n = 4) on ER and 146.7 nM  31.6 (mean + SEM; n = 5) on ER. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "early competition studies with 16-iodo-17-estradiol"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C0679932:competition [Social Behavior]
   744   C0947630:studies [Laboratory Procedure]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "(16IE2"

Phrase: ")"

Phrase: "and ["

Phrase: "3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol on ER"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   797   C0034803:Estradiol Receptor [Amino Acid, Peptide, or Protein,Receptor]
   797   C0034804:Estradiol Receptor [Amino Acid, Peptide, or Protein,Receptor]
   797   C1521863:Estradiol Receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   704 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   704 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that 16IE2"

Phrase: "was"

Phrase: "a very selective ER agonist,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2987634:Agonist [Pharmacologic Substance]

Phrase: "with an IC50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600495:IC50 [Quantitative Concept]

Phrase: "of 5.03 nM  1.33"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0312860:NM [Cell Function]
   804   C0439084:>5 [Quantitative Concept]
   804   C0728893:+5 [Quantitative Concept]

Phrase: "(mean + SEM"

Phrase: "; n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "on ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "146.7 nM  31.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0312860:NM [Cell Function]
   804   C0450355:31 [Intellectual Product]

Phrase: "(mean + SEM"

Phrase: "; n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "on ER."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.55: In contrast, the binding affinity of 17-iodovinyl-11-methoxyestradiol (125I-estrogen), a new radiolabeled estrogen, was similar on both ERs (Fig. 1), with an IC50 of 9.34 nM  0.54 (mean + SEM; n = 2) on ER and 13.3 nM  2.2 (mean + SEM; n = 2) on ER. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the binding affinity of 17-iodovinyl-11-methoxyestradiol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "(125I-estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "a new radiolabeled estrogen,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "similar on both ERs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "with an IC50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600495:IC50 [Quantitative Concept]

Phrase: "of 9.34 nM  0.54"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0312860:NM [Cell Function]

Phrase: "(mean + SEM"

Phrase: "; n = 2) on ER"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C1121713:Estrogen Receptor 2 [Amino Acid, Peptide, or Protein,Receptor]
   844   C1414462:ESTROGEN RECEPTOR 2 [Gene or Genome]
   844   C1523984:Estrogen Receptor 2 [Amino Acid, Peptide, or Protein,Receptor]
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441922:N+ [Intellectual Product]
   760   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "13.3 nM  2.2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0312860:NM [Cell Function]

Phrase: "(mean + SEM"

Phrase: "; n = 2) on ER."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C1121713:Estrogen Receptor 2 [Amino Acid, Peptide, or Protein,Receptor]
   844   C1414462:ESTROGEN RECEPTOR 2 [Gene or Genome]
   844   C1523984:Estrogen Receptor 2 [Amino Acid, Peptide, or Protein,Receptor]
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441922:N+ [Intellectual Product]
   760   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.56: In this assay, 17-estradiol also had a similar IC50 on ER and ER (3.9 nM and 5 nM, respectively; data not shown). 

Phrase: "In this assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "17-estradiol also"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   771 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   771 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "had"

Phrase: "a similar IC50 on ER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0600495:IC50 [Quantitative Concept]

Phrase: "and"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(3.9 nM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0312860:NM [Cell Function]
   734   C0442760:3/9 [Finding]

Phrase: "and"

Phrase: "5 nM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "respectively"

Phrase: "; data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.57: View larger version (23K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.58: A binding curve depicting the competition of several estrogenic compounds for [3H]17-estradiol binding to the ligand binding domain of ER or ER protein expressed in Escherichia coli. 

Phrase: "A binding curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205134:Curve [Spatial Concept]

Phrase: "depicting"

Phrase: "the competition of several estrogenic compounds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679932:competition [Social Behavior]

Phrase: "for"

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]17-estradiol binding to the ligand binding domain of ER"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   792   C1323334:ligand binding domain binding [Molecular Function]
   775   C0682969:Ligand Binding Domain [Amino Acid Sequence]
   772   C0597358:receptor ligand binding [Molecular Function]
   756   C1517880:Ligand Binding [Molecular Function]

Phrase: "or"

Phrase: "ER protein"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0059672:estrogen receptor protein [Amino Acid, Peptide, or Protein,Receptor]
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "expressed in Escherichia coli."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0014834:Escherichia coli [Bacterium]
   770   C0014833:Escherichia [Bacterium]
Processing 00000000.tx.59: Note the similar IC50 for 125I-estrogen on ER and ER, whereas 16-IE2 had a markedly higher affinity for ER when compared with ER.  

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the similar IC50 for 125I-estrogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0600495:IC50 [Quantitative Concept]

Phrase: "on ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ER,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "whereas"

Phrase: "16-IE2"

Phrase: "had"

Phrase: "a markedly higher affinity for ER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "when"

Phrase: "compared with ER."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   833   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   833   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C1707455:Compared [Activity]
   770   C2936882:Estrogen [Pharmacologic Substance]
Processing 00000000.tx.60: In an attempt to demonstrate that a functional ER protein is present in the wild-type and ERKO brain, the present study used 125I-estrogen because of its similar affinity for both ERs (Fig. 1). 

Phrase: "In an attempt to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516084:Attempt [Event]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "a functional ER protein"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   923   C0059672:estrogen receptor protein [Amino Acid, Peptide, or Protein,Receptor]
   861   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   861   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   861   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "present in the wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "ERKO brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "the present study used 125I-estrogen because of its similar affinity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   738   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "for both ERs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704489:ERS [Clinical Attribute]
  1000   C2931783:ERS [Disease or Syndrome]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.61: When 125I-estrogen was injected into wild-type mice (Figs. 2 and 3), cells with a nuclear uptake and retention of 125I-estrogen were seen in brain regions that predominantly contain ER (the ventromedial and arcuate nuclei, Fig. 2E), ER (the paraventricular nucleus, Fig. 2C; medial tuberal nucleus; entorhinal cortex; and dorsal raphe) or similar levels of both ERs (such as the preoptic area, Fig. 3A; bed nucleus of the stria terminalis, Fig. 3A; and amygdala). 

Phrase: "When"

Phrase: "125I-estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "injected into wild-type mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   828   C1520150:Wild Type Mouse [Mammal]
   806   C1883559:Wild Type [Organism Attribute]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   726   C1720154:Inject [Functional Concept]

Phrase: "(Figs. 2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "cells with a nuclear uptake"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "retention of 125I-estrogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035280:Retention [Mental Process]
   770   C0333117:Retention [Functional Concept]
   770   C1753315:retention [Cell Function]

Phrase: "were"

Phrase: "seen in brain regions"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C1273723:brain regions [Body Location or Region]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0205397:Seen [Qualitative Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737   C0017446:Region [Geographic Area]
   737 E C0042789:see [Organism Function]
   737   C0205147:Region [Spatial Concept]
   737 E C1947903:See [Activity]

Phrase: "that predominantly"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "the ventromedial"

Phrase: "and"

Phrase: "arcuate nuclei,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0003741:Arcuate Nucleus [Body Part, Organ, or Organ Component]
   861   C0205130:Arcuate [Spatial Concept]
   827   C0007610:Nucleus [Cell Component]

Phrase: "Fig. 2E"

Phrase: ")"

Phrase: ","

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "the paraventricular nucleus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030532:Paraventricular Nucleus [Body Part, Organ, or Organ Component]
  1000   C1289558:Paraventricular nucleus [Body Location or Region]
   861   C0007610:Nucleus [Cell Component]

Phrase: "Fig. 2C"

Phrase: "; medial tuberal nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007610:Nucleus [Cell Component]

Phrase: "; entorhinal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175196:Entorhinal Cortex [Body Part, Organ, or Organ Component]
  1000   C1289526:Entorhinal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: ";"

Phrase: "and"

Phrase: "dorsal raphe"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034671:RAPHE [Body Part, Organ, or Organ Component]
   861   C0205095:Dorsal [Spatial Concept]
   861   C0504074:Raphe [Body Space or Junction]

Phrase: ")"

Phrase: "or"

Phrase: "similar levels of both ERs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "("

Phrase: "such as the preoptic area,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033063:Preoptic Area [Body Part, Organ, or Organ Component]
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: "Fig. 3A"

Phrase: "; bed nucleus of the stria terminalis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0228365:Bed Nucleus of Stria Terminalis [Body Part, Organ, or Organ Component]
           Nucleus of Stria Terminalis
           Stria terminalis nucleus
   753   C0004916:Bed [Manufactured Object]
   753   C0007610:Nucleus [Cell Component]
   753   C0596170:BED [Mental or Behavioral Dysfunction]

Phrase: "Fig. 3A"

Phrase: ";"

Phrase: "and"

Phrase: "amygdala"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002708:Amygdala [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.62: In contrast, the distribution of 125I-estrogen binding sites seen in the ERKO brain (see Figs. 25) was more restricted than in wild-type animals, although the degree of nuclear labeling seen in the wild-type and ERKO brain was similar. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the distribution of 125I-estrogen binding sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "seen in the ERKO brain"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   778   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   748   C0205397:Seen [Qualitative Concept]
   748   C0560617:knock out [Injury or Poisoning]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1522225:Knock-out [Experimental Model of Disease]
   748   C2936882:Estrogen [Pharmacologic Substance]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Figs. 25"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: ")"

Phrase: "was"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "restricted than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0443288:Restricted [Functional Concept]

Phrase: "in wild-type animals,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003070:Animals, Wild [Animal]
   827   C0003062:Animals [Animal]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "although"

Phrase: "the degree of nuclear labeling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "seen in the wild-type"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0205397:Seen [Qualitative Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "and"

Phrase: "ERKO brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "similar."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.63: Cells with nuclear label were seen in the ERKO preoptic area (Figs. 3E, 4B), paraventricular nucleus of the hypothalamus (Fig. 2B), bed nucleus of the stria terminalis (Figs. 3E and 4, BD), medial amygdala (Fig. 4F), entorhinal cortex (Fig. 5D), hippocampus, and dorsal raphe (Fig. 5B). 

Phrase: "Cells with nuclear label"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seen in the ERKO preoptic area"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   770   C0033063:Preoptic Area [Body Part, Organ, or Organ Component]
   770   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   770   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   744   C0017446:Area [Geographic Area]
   744   C0205146:Area [Spatial Concept]
   744   C0205397:Seen [Qualitative Concept]
   744   C0560617:knock out [Injury or Poisoning]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1522225:Knock-out [Experimental Model of Disease]
   744   C2936882:Estrogen [Pharmacologic Substance]
   711 E C0042789:see [Organism Function]
   711 E C1947903:See [Activity]

Phrase: "(Figs. 3E,"

Phrase: "4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "paraventricular nucleus of the hypothalamus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   900   C0030532:Paraventricular nucleus of hypothalamus [Body Part, Organ, or Organ Component]
           Paraventricular Nucleus
   844   C2337556:Nucleus of hypothalamus [Body Part, Organ, or Organ Component]
   806   C1289558:Paraventricular nucleus [Body Location or Region]
   760   C0007610:Nucleus [Cell Component]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "bed nucleus of the stria terminalis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0228365:Bed Nucleus of Stria Terminalis [Body Part, Organ, or Organ Component]
           Nucleus of Stria Terminalis
           Stria terminalis nucleus
   753   C0004916:Bed [Manufactured Object]
   753   C0007610:Nucleus [Cell Component]
   753   C0596170:BED [Mental or Behavioral Dysfunction]

Phrase: "(Figs. 3E"

Phrase: "and"

Phrase: "4,"

Phrase: "BD"

Phrase: ")"

Phrase: ","

Phrase: "medial amygdala"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0002708:Amygdala [Body Part, Organ, or Organ Component]
   861   C0205098:Medial [Spatial Concept]

Phrase: "(Fig. 4F"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450379:4f [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "entorhinal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175196:Entorhinal Cortex [Body Part, Organ, or Organ Component]
  1000   C1289526:Entorhinal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "(Fig. 5D"

Phrase: ")"

Phrase: ","

Phrase: "hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "dorsal raphe"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034671:RAPHE [Body Part, Organ, or Organ Component]
   861   C0205095:Dorsal [Spatial Concept]
   861   C0504074:Raphe [Body Space or Junction]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.64: A comparison of the distribution of ER mRNA in the ERKO brain (Figs. 2A; 4, A and E; and 5, A and C) with the distribution of 125I-estrogen-labeled cells (Figs. 2B; 4, B and F; and 5, B and D), revealed that binding was detected in subregions of the brain where ER was expressed. 

Phrase: "A comparison of the distribution of ER mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1707455:Comparison [Activity]

Phrase: "in the ERKO brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(Figs. 2A"

Phrase: "; 4,"

Phrase: "A"

Phrase: "and"

Phrase: "E"

Phrase: ";"

Phrase: "and"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "A"

Phrase: "and"

Phrase: "C) with the distribution of 125I-estrogen-labeled cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C0229579:C-Cell [Cell]
   742   C1553033:[c] [Quantitative Concept]

Phrase: "(Figs. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "; 4,"

Phrase: "B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: ";"

Phrase: "and"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "D)"

Phrase: ","

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "detected in subregions of the brain where ER"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   764   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   764   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   742   C0442726:Detected [Finding]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
   742   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "was"

Phrase: "expressed."
Processing 00000000.tx.65: Moreover, there was a positive correlation between the degree of 125I-estrogen binding and the intensity of ER hybridization signal, with areas such as the bed nucleus of the stria terminalis (Fig. 4A), paraventricular nucleus (Fig. 2A), medial amygdala (Fig. 4E), and dorsal raphe (Fig. 5A) containing the highest levels of ER mRNA and 125I-estrogen binding. 

Phrase: "Moreover,"

Phrase: "there"

Phrase: "was"

Phrase: "a positive correlation between the degree of 125I-estrogen binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "the intensity of ER hybridization signal,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0871362:signal intensity [Quantitative Concept]
   748   C0522510:Intensity [Qualitative Concept]

Phrase: "with areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205146:areas [Spatial Concept]
   966 E C0017446:Area [Geographic Area]

Phrase: "such as the bed nucleus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004916:Bed [Manufactured Object]
   861   C0007610:Nucleus [Cell Component]
   861   C0596170:BED [Mental or Behavioral Dysfunction]

Phrase: "of the stria terminalis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175243:Stria terminalis [Body Part, Organ, or Organ Component]
   861   C1253938:Stria [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "paraventricular nucleus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030532:Paraventricular Nucleus [Body Part, Organ, or Organ Component]
  1000   C1289558:Paraventricular nucleus [Body Location or Region]
   861   C0007610:Nucleus [Cell Component]

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: ","

Phrase: "medial amygdala"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0002708:Amygdala [Body Part, Organ, or Organ Component]
   861   C0205098:Medial [Spatial Concept]

Phrase: "(Fig. 4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "dorsal raphe"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034671:RAPHE [Body Part, Organ, or Organ Component]
   861   C0205095:Dorsal [Spatial Concept]
   861   C0504074:Raphe [Body Space or Junction]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the highest levels of ER mRNA"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "125I-estrogen binding."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
Processing 00000000.tx.66: Competition studies with 17-estradiol (Fig. 3, D and F), but not dihydrotestosterone (Fig. 3B) and R5020, eliminated the nuclear uptake and retention of radiolabeled ligand seen in the ERKO (Fig. 3E) and wild-type (Fig. 3A) brain, thus demonstrating the specificity of 125I-estrogen for ER. 

Phrase: "Competition studies with 17-estradiol"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0679932:competition [Social Behavior]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "F),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "but"

Phrase: "not dihydrotestosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038148:Dihydrotestosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: "and"

Phrase: "R5020,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878080:R5020 [Hormone,Pharmacologic Substance,Steroid]

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "the nuclear uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "retention of radiolabeled ligand"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035280:Retention [Mental Process]
   770   C0333117:Retention [Functional Concept]
   770   C1753315:retention [Cell Function]

Phrase: "seen in the ERKO"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   790   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   790   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   753   C0205397:Seen [Qualitative Concept]
   753   C0560617:knock out [Injury or Poisoning]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1522225:Knock-out [Experimental Model of Disease]
   753   C2936882:Estrogen [Pharmacologic Substance]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: "(Fig. 3E"

Phrase: ")"

Phrase: "and"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(Fig. 3A"

Phrase: ")"

Phrase: "brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "thus"

Phrase: "demonstrating"

Phrase: "the specificity of 125I-estrogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "for ER."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.67: Because 16IE2 is an ER selective agonist (Fig. 1), this compound was used as a competitor to further characterize the binding of 125I-estrogen in wild-type and ERKO mice. 

Phrase: "Because"

Phrase: "16IE2"

Phrase: "is"

Phrase: "an ER selective agonist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2987634:Agonist [Pharmacologic Substance]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "this compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205198:Compound [Qualitative Concept]
  1000   C1706082:Compound [Chemical]

Phrase: "was"

Phrase: "used as a competitor"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "to further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "characterize"

Phrase: "the binding of 125I-estrogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "in wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "ERKO mice."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   861   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0206745:Knock-out Mice [Mammal]
   861   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   861   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0560617:knock out [Injury or Poisoning]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1522225:Knock-out [Experimental Model of Disease]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.68: When ERKO mice were injected with a 125-fold excess of 16IE2 before 125I-estrogen, only a slight attenuation in binding was observed. 

Phrase: "When"

Phrase: "ERKO mice"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   861   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0206745:Knock-out Mice [Mammal]
   861   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   861   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0560617:knock out [Injury or Poisoning]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1522225:Knock-out [Experimental Model of Disease]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "injected with a 125-fold excess of 16IE2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0332462:Fold [Spatial Concept]
   744   C1880834:FOLD [Phenomenon or Process]
   744   C1979886:Excess [Qualitative Concept]
   711   C1720154:Inject [Functional Concept]

Phrase: "before 125I-estrogen,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a slight attenuation in binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0599946:Attenuation [Activity]

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.69: In contrast, injection of wild-type animals with 16IE2 before 125I-estrogen eliminated ER binding sites (Figs. 2, E vs. F; and 3, A vs. C) and resulted in a pattern of binding that was comparable to the ERKO brain (Figs. 2, B vs. D; and 3, C vs. E). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "injection of wild-type animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021485:injection [Therapeutic or Preventive Procedure]
   760   C1272883:Injection [Biomedical or Dental Material]
   760   C1533685:Injection [Therapeutic or Preventive Procedure]
   760   C1828121:Injection [Functional Concept]

Phrase: "with 16IE2"

Phrase: "before 125I-estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "ER binding sites"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0684162:receptor binding sites [Receptor]
   906   C0034804:Estrogen receptor site [Amino Acid, Peptide, or Protein,Receptor]
   875   C0005456:RECEPTOR SITES [Receptor]
           Binding Sites
   827 E C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]
   756   C1149369:estrogen receptor binding [Molecular Function]

Phrase: "(Figs. 2,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "E"

Phrase: "vs. F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: ";"

Phrase: "and"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "A"

Phrase: "vs. C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "resulted in a pattern of binding"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C1523331:pattern binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C0449774:Pattern [Spatial Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "that"

Phrase: "was"

Phrase: "comparable to the ERKO brain"

Phrase: "(Figs. 2,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "vs. D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";"

Phrase: "and"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "C"

Phrase: "vs. E"

Phrase: ")."
Processing 00000000.tx.70: In particular, brain regions such as the ventromedial and arcuate nuclei (Fig. 2E) contained little or no 125I-estrogen binding, whereas labeling in the paraventricular nucleus (Fig. 2D) and medial amygdala were not markedly attenuated. 

Phrase: "In particular, brain regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C1273723:brain regions [Body Location or Region]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "such as the ventromedial"

Phrase: "and"

Phrase: "arcuate nuclei"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0003741:Arcuate Nucleus [Body Part, Organ, or Organ Component]
   861   C0205130:Arcuate [Spatial Concept]
   827   C0007610:Nucleus [Cell Component]

Phrase: "(Fig. 2E"

Phrase: ")"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no 125I-estrogen binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "whereas"

Phrase: "labeling in the paraventricular nucleus"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0030532:Paraventricular Nucleus [Body Part, Organ, or Organ Component]
   806   C1289558:Paraventricular nucleus [Body Location or Region]
   760   C0007610:Nucleus [Cell Component]
   760   C1167624:Labeling [Mental Process]
   760   C1947902:Labeling [Manufactured Object]
   760   C2827499:Labeling [Governmental or Regulatory Activity]
   726 E C0181496:Label [Manufactured Object]

Phrase: "(Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "medial amygdala"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0002708:Amygdala [Body Part, Organ, or Organ Component]
   861   C0205098:Medial [Spatial Concept]

Phrase: "were"

Phrase: "not markedly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0522501:Markedly [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "attenuated."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]
Processing 00000000.tx.71: View larger version (166K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(166K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.72: Autoradiographic images of ER mRNA (A) or 125I-estrogen binding (BF) in the paraventricular nucleus (AD) and medial basal hypothalamus (EF) of ERKO (AB) and wild-type (CF) female mice by in situ hybridization (A) or in vivo binding (BF). 

Phrase: "Autoradiographic images of ER mRNA ("
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C2986957:Autoradiographic Image [Manufactured Object]
   714   C1704254:Image [Intellectual Product]
   714   C1704922:Image [Entity]
   714   C3542466:Image [Intellectual Product]

Phrase: "A)"

Phrase: "or"

Phrase: "125I-estrogen binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "(BF) in the paraventricular nucleus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0006409:BF [Geographic Area]
   760   C1824728:BF [Gene or Genome]

Phrase: "(AD)"

Phrase: "and"

Phrase: "medial basal hypothalamus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0020669:Hypothalamus, Medial [Body Part, Organ, or Organ Component]
   827   C0020663:Hypothalamus [Body Part, Organ, or Organ Component]
   827   C1280712:Hypothalamus [Body Part, Organ, or Organ Component]

Phrase: "(EF) of ERKO"

Phrase: "(AB)"

Phrase: "and"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(CF) female mice by in situ hybridization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]

Phrase: "(A)"

Phrase: "or"

Phrase: "in vivo binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "(BF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006409:BF [Geographic Area]
  1000   C1824728:BF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.73: A comparison of the distribution of ER mRNA (A) with 125I-estrogen binding (B) in the ERKO paraventricular nucleus suggests that the radiolabeled ligand binds to ER. 

Phrase: "A comparison of the distribution of ER mRNA ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1707455:Comparison [Activity]

Phrase: "A) with 125I-estrogen binding (B)"

Phrase: "in the ERKO paraventricular nucleus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0030532:Paraventricular Nucleus [Body Part, Organ, or Organ Component]
   840   C1289558:Paraventricular nucleus [Body Location or Region]
   804   C0007610:Nucleus [Cell Component]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the radiolabeled ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligand [Chemical]

Phrase: "binds to ER."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   833   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   833   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C2936882:Estrogen [Pharmacologic Substance]
Processing 00000000.tx.74: In the wild-type brain, 125I-estrogen binding was also seen in the paraventricular nucleus, as well as regions where ER is expressed including, the anterior hypothalamic (C), ventromedial (E) and arcuate (E) nuclei. 

Phrase: "In the wild-type brain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "125I-estrogen binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "also"

Phrase: "seen in the paraventricular nucleus,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0030532:Paraventricular Nucleus [Body Part, Organ, or Organ Component]
   806   C1289558:Paraventricular nucleus [Body Location or Region]
   760   C0007610:Nucleus [Cell Component]
   760   C0205397:Seen [Qualitative Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "as well as"

Phrase: "regions where ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   861   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "expressed"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: ","

Phrase: "the anterior hypothalamic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020663:Hypothalamic [Body Part, Organ, or Organ Component]

Phrase: "(C), ventromedial"

Phrase: "(E)"

Phrase: "and"

Phrase: "arcuate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205130:Arcuate [Spatial Concept]

Phrase: "(E) nuclei."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.75: Note that the treatment of wild-type females with an ER selective agonist (16IE2) before the injection of 125I-estrogen, eliminated specific binding in areas where ER is expressed (F and the anterior hypothalamic nucleus in D), but had little or no effect on binding in the paraventricular nucleus (D). 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the treatment of wild-type females"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "with an ER selective agonist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2987634:Agonist [Pharmacologic Substance]

Phrase: "(16IE2"

Phrase: ")"

Phrase: "before the injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "of 125I-estrogen,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "specific binding in areas where ER"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C1149369:estrogen receptor binding [Molecular Function]
   774   C0597358:Receptor Binding [Molecular Function]
   748   C0205369:Specific [Qualitative Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1552740:specific [Intellectual Product]

Phrase: "is"

Phrase: "expressed"

Phrase: "(F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "the anterior hypothalamic nucleus in"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0020653:Anterior Hypothalamic Nucleus [Body Part, Organ, or Organ Component]
   862   C1289560:Anterior hypothalamic nucleus [Body Location or Region]
   806   C0458371:Hypothalamic nucleus [Body Part, Organ, or Organ Component]
   760   C0007610:Nucleus [Cell Component]
   760   C0020663:Hypothalamic [Body Part, Organ, or Organ Component]
   760   C0205094:Anterior [Spatial Concept]

Phrase: "D)"

Phrase: ","

Phrase: "but"

Phrase: "had"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no effect on binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "in the paraventricular nucleus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030532:Paraventricular Nucleus [Body Part, Organ, or Organ Component]
  1000   C1289558:Paraventricular nucleus [Body Location or Region]
   861   C0007610:Nucleus [Cell Component]

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.76: Asterisks indicate the third ventricle of the hypothalamus. 

Phrase: "Asterisks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisks [Conceptual Entity]

Phrase: "indicate"

Phrase: "the third ventricle of the hypothalamus."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0149555:Third Ventricle [Body Space or Junction]
   790   C1268983:Third ventricle [Body Space or Junction]
   753   C0018827:Ventricle [Body Part, Organ, or Organ Component]
   753   C0205437:Third [Quantitative Concept]
   753   C2355627:Ventricle [Body Part, Organ, or Organ Component]
Processing 00000000.tx.77: Designation of structures: ARC, arcuate nucleus; 

Phrase: "Designation of structures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0600091:Designation [Intellectual Product]
   790   C1510813:Designation [Conceptual Entity]

Phrase: ":"

Phrase: "ARC,"

Phrase: "arcuate nucleus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003741:Arcuate Nucleus [Body Part, Organ, or Organ Component]
   861   C0007610:Nucleus [Cell Component]
   861   C0205130:Arcuate [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.78: PVN, paraventricular hypothalamic nucleus; 

Phrase: "PVN,"

Phrase: "paraventricular hypothalamic nucleus"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030532:Paraventricular Hypothalamic Nucleus [Body Part, Organ, or Organ Component]
           Paraventricular Nucleus
   913   C1289558:Paraventricular nucleus [Body Location or Region]
   901   C0458371:Hypothalamic nucleus [Body Part, Organ, or Organ Component]
   827   C0007610:Nucleus [Cell Component]
   827   C0020663:Hypothalamic [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.79: VMN, ventromedial nucleus. 

Phrase: "VMN,"

Phrase: "ventromedial nucleus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.80: Autoradiographic exposure time: 1428 days.  

Phrase: "Autoradiographic exposure time"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C2348485:Exposure Time [Quantitative Concept]
   827   C0040223:Time [Temporal Concept]
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: ":"

Phrase: "1428 days."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.81: View larger version (81K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(81K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.82: Autoradiographic images of 125I-estrogen binding in the anterior hypothalamus of wild-type (AD) and ERKO (EF) female mice by in vivo autoradiography. 

Phrase: "Autoradiographic images of 125I-estrogen binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C2986957:Autoradiographic Image [Manufactured Object]
   719   C1704254:Image [Intellectual Product]
   719   C1704922:Image [Entity]
   719   C3542466:Image [Intellectual Product]

Phrase: "in the anterior hypothalamus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020664:Hypothalamus, Anterior [Body Part, Organ, or Organ Component]
   861   C0020663:Hypothalamus [Body Part, Organ, or Organ Component]
   861   C0205094:Anterior [Spatial Concept]
   861   C1280712:Hypothalamus [Body Part, Organ, or Organ Component]

Phrase: "of wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(AD)"

Phrase: "and"

Phrase: "ERKO"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0560617:knock out [Injury or Poisoning]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1522225:Knock-out [Experimental Model of Disease]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(EF) female mice by in vivo autoradiography."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
Processing 00000000.tx.83: In the wild-type brain, 125I-estrogen binding was seen in the medial preoptic area and bed nucleus of the stria terminalis (A), whereas the majority of binding seen in the ERKO brain was localized in the bed nucleus of the stria terminalis (E). 

Phrase: "In the wild-type brain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "125I-estrogen binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "seen in the medial preoptic area"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0175313:Medial preoptic area [Body Part, Organ, or Organ Component]
   790   C0033063:Preoptic Area [Body Part, Organ, or Organ Component]
   753   C0017446:Area [Geographic Area]
   753   C0205098:Medial [Spatial Concept]
   753   C0205146:Area [Spatial Concept]
   753   C0205397:Seen [Qualitative Concept]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: "and"

Phrase: "bed nucleus of the stria terminalis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0228365:Bed Nucleus of Stria Terminalis [Body Part, Organ, or Organ Component]
           Nucleus of Stria Terminalis
           Stria terminalis nucleus
   753   C0004916:Bed [Manufactured Object]
   753   C0007610:Nucleus [Cell Component]
   753   C0596170:BED [Mental or Behavioral Dysfunction]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the majority of binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "seen in the ERKO brain"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   778   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   748   C0205397:Seen [Qualitative Concept]
   748   C0560617:knock out [Injury or Poisoning]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1522225:Knock-out [Experimental Model of Disease]
   748   C2936882:Estrogen [Pharmacologic Substance]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]

Phrase: "was"

Phrase: "localized in the bed nucleus of the stria terminalis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   832   C0228365:Bed Nucleus of Stria Terminalis [Body Part, Organ, or Organ Component]
           Nucleus of Stria Terminalis
           Stria terminalis nucleus
   764   C0175243:Stria terminalis [Body Part, Organ, or Organ Component]
   742   C0004916:Bed [Manufactured Object]
   742   C0007610:Nucleus [Cell Component]
   742   C0392752:Localized [Spatial Concept]
   742   C0596170:BED [Mental or Behavioral Dysfunction]
   742   C1253938:Stria [Body Part, Organ, or Organ Component]

Phrase: "(E"

Phrase: ")."
Processing 00000000.tx.84: Competition studies with 17-estradiol eliminated specific binding in these brain regions (D and F), whereas DHT had no effect (B). 

Phrase: "Competition studies with 17-estradiol"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0679932:competition [Social Behavior]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "specific binding in these brain regions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205369:Specific [Qualitative Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1552740:specific [Intellectual Product]

Phrase: "(D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "F),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "whereas"

Phrase: "DHT"

Phrase: "had"

Phrase: "no effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "(B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: ")."
Processing 00000000.tx.85: When wild-type females were treated with an ER selective agonist (16IE2) before the injection of 125I-estrogen, the majority of the binding seen in the preoptic area was eliminated, whereas some binding was still seen in the bed nucleus of the stria terminalis (C). 

Phrase: "When"

Phrase: "wild-type females"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0015780:Females [Finding]
   827   C0086287:Females [Population Group]
   793 E C0043210:female [Population Group]
   793 E C1705497:Female [Qualitative Concept]
   793 E C1705498:Female [Qualitative Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "were"

Phrase: "treated with an ER selective agonist"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   778   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   778   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1522326:Treated [Functional Concept]
   748   C2936882:Estrogen [Pharmacologic Substance]
   748   C2987634:Agonist [Pharmacologic Substance]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "(16IE2"

Phrase: ")"

Phrase: "before the injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "of 125I-estrogen,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "the majority of the binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "seen in the preoptic area"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0033063:Preoptic Area [Body Part, Organ, or Organ Component]
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]
   760   C0205397:Seen [Qualitative Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "was"

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: ","

Phrase: "whereas"

Phrase: "some"

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "still"

Phrase: "seen in the bed nucleus of the stria terminalis"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   832   C0228365:Bed Nucleus of Stria Terminalis [Body Part, Organ, or Organ Component]
           Nucleus of Stria Terminalis
           Stria terminalis nucleus
   764   C0175243:Stria terminalis [Body Part, Organ, or Organ Component]
   742   C0004916:Bed [Manufactured Object]
   742   C0007610:Nucleus [Cell Component]
   742   C0205397:Seen [Qualitative Concept]
   742   C0596170:BED [Mental or Behavioral Dysfunction]
   742   C1253938:Stria [Body Part, Organ, or Organ Component]
   708 E C0042789:see [Organism Function]
   708 E C1947903:See [Activity]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.86: The residual binding seen in the bed nucleus of the stria terminalis (C) was similar to the binding seen in the ERKO brain (E), suggesting that this is due to the interaction with ER. 

Phrase: "The residual binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "seen in the bed nucleus of the stria terminalis"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   832   C0228365:Bed Nucleus of Stria Terminalis [Body Part, Organ, or Organ Component]
           Nucleus of Stria Terminalis
           Stria terminalis nucleus
   764   C0175243:Stria terminalis [Body Part, Organ, or Organ Component]
   742   C0004916:Bed [Manufactured Object]
   742   C0007610:Nucleus [Cell Component]
   742   C0205397:Seen [Qualitative Concept]
   742   C0596170:BED [Mental or Behavioral Dysfunction]
   742   C1253938:Stria [Body Part, Organ, or Organ Component]
   708 E C0042789:see [Organism Function]
   708 E C1947903:See [Activity]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "was"

Phrase: "similar to the binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "seen in the ERKO brain"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   778   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   748   C0205397:Seen [Qualitative Concept]
   748   C0560617:knock out [Injury or Poisoning]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1522225:Knock-out [Experimental Model of Disease]
   748   C2936882:Estrogen [Pharmacologic Substance]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]

Phrase: "(E"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this"

Phrase: "is due to the interaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0678226:Due to [Functional Concept]
           due
   760   C1704675:Interaction [Functional Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "with ER."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.87: Designation of structures: BST, bed nucleus of the stria terminalis; 

Phrase: "Designation of structures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0600091:Designation [Intellectual Product]
   790   C1510813:Designation [Conceptual Entity]

Phrase: ":"

Phrase: "BST,"

Phrase: "bed nucleus of the stria terminalis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0228365:Bed Nucleus of Stria Terminalis [Body Part, Organ, or Organ Component]
           Nucleus of Stria Terminalis
           Stria terminalis nucleus
   753   C0004916:Bed [Manufactured Object]
   753   C0007610:Nucleus [Cell Component]
   753   C0596170:BED [Mental or Behavioral Dysfunction]

Phrase: ";"
Processing 00000000.tx.88: MPA, medial preoptic area. 

Phrase: "MPA,"

Phrase: "medial preoptic area."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175313:Medial preoptic area [Body Part, Organ, or Organ Component]
   901   C0033063:Preoptic Area [Body Part, Organ, or Organ Component]
   827   C0017446:Area [Geographic Area]
   827   C0205098:Medial [Spatial Concept]
   827   C0205146:Area [Spatial Concept]
Processing 00000000.tx.89: Autoradiographic film exposure time: 16 h.  

Phrase: "Autoradiographic film exposure time"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C2348485:Exposure Time [Quantitative Concept]
   812   C0040223:Time [Temporal Concept]
   812   C0274281:Exposure, NOS [Injury or Poisoning]
   812   C0332157:Exposure [Clinical Attribute]
   812   C3541383:Time [Temporal Concept]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   729 E C1632851:Times [Quantitative Concept]

Phrase: ":"

Phrase: "16 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.90: View larger version (166K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(166K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.91: Autoradiographic images of ER mRNA (A and E) or 125I-estrogen binding (BD and F) in the bed nucleus of the stria terminalis/preoptic area (AD) or medial amygdala (EF) of ERKO female mice by in situ hybridization or in vivo binding. 

Phrase: "Autoradiographic images of ER mRNA (A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C2986957:Autoradiographic Image [Manufactured Object]
   711   C1704254:Image [Intellectual Product]
   711   C1704922:Image [Entity]
   711   C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "E)"

Phrase: "or"

Phrase: "125I-estrogen binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "(BD"

Phrase: "and"

Phrase: "F) in the bed nucleus of the stria terminalis/preoptic area"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   738   C0439133:(f) [Intellectual Product]
   738   C1553038:[f] [Quantitative Concept]

Phrase: "(AD)"

Phrase: "or"

Phrase: "medial amygdala"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0002708:Amygdala [Body Part, Organ, or Organ Component]
   861   C0205098:Medial [Spatial Concept]

Phrase: "(EF) of ERKO female mice"

Phrase: "by in situ hybridization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   901   C0444498:In situ [Spatial Concept]
   827   C0020202:Hybridisation [Genetic Function]
   827   C1300517:Hybridization [Laboratory Procedure]

Phrase: "or"

Phrase: "in vivo binding."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   734   C1515655:In Vivo [Spatial Concept]
Processing 00000000.tx.92: Note the similar localization of ER mRNA and 125I-estrogen binding in these brain regions. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the similar localization of ER mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1158693:RNA localisation [Cell Function]
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "125I-estrogen binding in these brain regions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
Processing 00000000.tx.93: It is also interesting to note that brain regions that have the highest level of ER expression (bed nucleus of the stria terminalis, A; medial amygdala, E), also have the strongest nuclear uptake and retention of 125I-estrogen (B and F, respectively), whereas regions with a low level of ER mRNA (preoptic area, A) had only weak binding (B). 

Phrase: "It"

Phrase: "is"

Phrase: "also"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that brain regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C1273723:brain regions [Body Location or Region]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "that"

Phrase: "have"

Phrase: "the highest level of ER expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C3244092:expression level [Idea or Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "(bed nucleus of the stria terminalis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0228365:Bed Nucleus of Stria Terminalis [Body Part, Organ, or Organ Component]
           Nucleus of Stria Terminalis
           Stria terminalis nucleus
   753   C0004916:Bed [Manufactured Object]
   753   C0007610:Nucleus [Cell Component]
   753   C0596170:BED [Mental or Behavioral Dysfunction]

Phrase: "A"

Phrase: "; medial amygdala,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0002708:Amygdala [Body Part, Organ, or Organ Component]
   861   C0205098:Medial [Spatial Concept]

Phrase: "E"

Phrase: ")"

Phrase: ","

Phrase: "also"

Phrase: "have"

Phrase: "the strongest nuclear uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "retention of 125I-estrogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035280:Retention [Mental Process]
   770   C0333117:Retention [Functional Concept]
   770   C1753315:retention [Cell Function]

Phrase: "(B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "regions with a low level"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0683928:regional level [Spatial Concept]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "of ER mRNA (preoptic area,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033063:Preoptic Area [Body Part, Organ, or Organ Component]
   799   C0017446:Area [Geographic Area]
   799   C0205146:Area [Spatial Concept]

Phrase: "A)"

Phrase: "had"

Phrase: "only weak binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "(B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: ")."
Processing 00000000.tx.94: Asterisks indicate the third ventricle of the hypothalamus. 

Phrase: "Asterisks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisks [Conceptual Entity]

Phrase: "indicate"

Phrase: "the third ventricle of the hypothalamus."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0149555:Third Ventricle [Body Space or Junction]
   790   C1268983:Third ventricle [Body Space or Junction]
   753   C0018827:Ventricle [Body Part, Organ, or Organ Component]
   753   C0205437:Third [Quantitative Concept]
   753   C2355627:Ventricle [Body Part, Organ, or Organ Component]
Processing 00000000.tx.95: Designation of structures: BST, bed nucleus of the stria terminalis; 

Phrase: "Designation of structures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0600091:Designation [Intellectual Product]
   790   C1510813:Designation [Conceptual Entity]

Phrase: ":"

Phrase: "BST,"

Phrase: "bed nucleus of the stria terminalis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0228365:Bed Nucleus of Stria Terminalis [Body Part, Organ, or Organ Component]
           Nucleus of Stria Terminalis
           Stria terminalis nucleus
   753   C0004916:Bed [Manufactured Object]
   753   C0007610:Nucleus [Cell Component]
   753   C0596170:BED [Mental or Behavioral Dysfunction]

Phrase: ";"
Processing 00000000.tx.96: LV, lateral ventricle; 

Phrase: "LV,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023128:LV [Geographic Area]
  1000   C0731033:LV [Organic Chemical,Pharmacologic Substance,Vitamin]
  1000   C1881413:LV [Chemical Viewed Structurally]

Phrase: "lateral ventricle"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0152279:Lateral ventricle [Body Space or Junction]
  1000   C1268982:Lateral ventricle [Body Space or Junction]
   861   C0018827:Ventricle [Body Part, Organ, or Organ Component]
   861   C0205093:Lateral [Spatial Concept]
   861   C2355627:Ventricle [Body Part, Organ, or Organ Component]
   789 E C1522565:Ventricular [Spatial Concept]
   761 E C0038351:Ventriculus [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.97: MPA, medial preoptic area; 

Phrase: "MPA,"

Phrase: "medial preoptic area"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175313:Medial preoptic area [Body Part, Organ, or Organ Component]
   901   C0033063:Preoptic Area [Body Part, Organ, or Organ Component]
   827   C0017446:Area [Geographic Area]
   827   C0205098:Medial [Spatial Concept]
   827   C0205146:Area [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.98: ot, optic tract. 

Phrase: "ot,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418208:OT [Gene or Genome]
  1000   C1705587:OT [Gene or Genome]

Phrase: "optic tract."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0152405:Optic Tract [Body Part, Organ, or Organ Component]
  1000   C1269601:Optic tract [Body Part, Organ, or Organ Component]
   861   C0015392:Optic [Body Part, Organ, or Organ Component]
   861   C0029144:optic [Occupation or Discipline]
   861   C1185740:Tract [Body Part, Organ, or Organ Component]
Processing 00000000.tx.99: Autoradiographic exposure time: 1428 days.  

Phrase: "Autoradiographic exposure time"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C2348485:Exposure Time [Quantitative Concept]
   827   C0040223:Time [Temporal Concept]
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: ":"

Phrase: "1428 days."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.100: View larger version (126K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(126K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.101: Autoradiographic images of ER mRNA (A and C) or 125I-estrogen binding (B and D) in the dorsal raphe (AB) or entorhinal cortex (CD) of ERKO female mice by in situ hybridization or in vivo binding. 

Phrase: "Autoradiographic images of ER mRNA (A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C2986957:Autoradiographic Image [Manufactured Object]
   711   C1704254:Image [Intellectual Product]
   711   C1704922:Image [Entity]
   711   C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "or"

Phrase: "125I-estrogen binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "(B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "D) in the dorsal raphe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034671:RAPHE [Body Part, Organ, or Organ Component]
   760   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0205095:Dorsal [Spatial Concept]
   760   C0504074:Raphe [Body Space or Junction]

Phrase: "(AB)"

Phrase: "or"

Phrase: "entorhinal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175196:Entorhinal Cortex [Body Part, Organ, or Organ Component]
  1000   C1289526:Entorhinal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "(CD) of ERKO female mice"

Phrase: "by in situ hybridization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   901   C0444498:In situ [Spatial Concept]
   827   C0020202:Hybridisation [Genetic Function]
   827   C1300517:Hybridization [Laboratory Procedure]

Phrase: "or"

Phrase: "in vivo binding."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   734   C1515655:In Vivo [Spatial Concept]
Processing 00000000.tx.102: Note the similar localization of ER mRNA and 125I-estrogen binding in the dorsal raphe and medial portion of the entorhinal cortex and the relationship between the level of ER expression (A and C) and degree of nuclear uptake and retention of 125I-estrogen (B and D). 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the similar localization of ER mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1158693:RNA localisation [Cell Function]
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "125I-estrogen binding in the dorsal raphe"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "medial portion of the entorhinal cortex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449719:Portion [Spatial Concept]

Phrase: "and"

Phrase: "the relationship between the level of ER expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0439849:Relationship [Qualitative Concept]
   742   C1705630:Relationship [Idea or Concept]
   742   C1706279:Relationship [Idea or Concept]
   742   C3540605:Relationship [Intellectual Product]

Phrase: "(A"

Phrase: "and"

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "degree of nuclear uptake"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "and"

Phrase: "retention of 125I-estrogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035280:Retention [Mental Process]
   770   C0333117:Retention [Functional Concept]
   770   C1753315:retention [Cell Function]

Phrase: "(B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.103: Designation of structures: Aq, aqueduct; 

Phrase: "Designation of structures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0600091:Designation [Intellectual Product]
   790   C1510813:Designation [Conceptual Entity]

Phrase: ":"

Phrase: "Aq,"

Phrase: "aqueduct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007769:Aqueduct [Body Space or Junction]
  1000   C0228168:Aqueduct [Body Space or Junction]

Phrase: ";"
Processing 00000000.tx.104: DR, dorsal raphe; 

Phrase: "DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]

Phrase: "dorsal raphe"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034671:RAPHE [Body Part, Organ, or Organ Component]
   861   C0205095:Dorsal [Spatial Concept]
   861   C0504074:Raphe [Body Space or Junction]

Phrase: ";"
Processing 00000000.tx.105: Entl, entorhinal cortex lateral portion; 

Phrase: "Entl,"

Phrase: "entorhinal cortex lateral portion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205093:Lateral [Spatial Concept]
   812   C0449719:Portion [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.106: Entm, entorhinal cortex medial portion. 

Phrase: "Entm,"

Phrase: "entorhinal cortex medial portion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449719:Portion [Spatial Concept]
Processing 00000000.tx.107: Autoradiographic exposure time: 1428 days.   

Phrase: "Autoradiographic exposure time"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C2348485:Exposure Time [Quantitative Concept]
   827   C0040223:Time [Temporal Concept]
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: ":"

Phrase: "1428 days."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.108: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  The present studies used a new radiolabeled estrogen (125I-estrogen, 12), that has an equal binding affinity for ER and ER, to assess the distribution of residual binding sites in the ERKO brain. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The present studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a new radiolabeled estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(125I-estrogen,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "12"

Phrase: ")"

Phrase: ","

Phrase: "that"

Phrase: "has"

Phrase: "an equal binding affinity for ER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "ER,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the distribution of residual binding sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "in the ERKO brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.109: Nuclear uptake and retention of 125I-estrogen was seen in regions of the ERKO mouse brain where ER is expressed, including the preoptic area, bed nucleus of the stria terminalis, paraventricular nucleus, amygdala, entorhinal cortex, and dorsal raphe (13). 

Phrase: "Nuclear uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "retention of 125I-estrogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035280:Retention [Mental Process]
   770   C0333117:Retention [Functional Concept]
   770   C1753315:retention [Cell Function]

Phrase: "was"

Phrase: "seen in regions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   756   C0017446:Region [Geographic Area]
   756 E C0042789:see [Organism Function]
   756   C0205147:Region [Spatial Concept]
   756 E C1947903:See [Activity]
   706 E C0205276:Regional [Spatial Concept]
   706 E C1947913:Regional [Spatial Concept]

Phrase: "of the ERKO mouse brain where ER"

Phrase: "is"

Phrase: "expressed"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the preoptic area,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033063:Preoptic Area [Body Part, Organ, or Organ Component]
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: "bed nucleus of the stria terminalis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0228365:Bed Nucleus of Stria Terminalis [Body Part, Organ, or Organ Component]
           Nucleus of Stria Terminalis
           Stria terminalis nucleus
   753   C0004916:Bed [Manufactured Object]
   753   C0007610:Nucleus [Cell Component]
   753   C0596170:BED [Mental or Behavioral Dysfunction]

Phrase: "paraventricular nucleus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030532:Paraventricular Nucleus [Body Part, Organ, or Organ Component]
  1000   C1289558:Paraventricular nucleus [Body Location or Region]
   861   C0007610:Nucleus [Cell Component]

Phrase: "amygdala,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002708:Amygdala [Body Part, Organ, or Organ Component]

Phrase: "entorhinal cortex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175196:Entorhinal Cortex [Body Part, Organ, or Organ Component]
  1000   C1289526:Entorhinal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "dorsal raphe"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034671:RAPHE [Body Part, Organ, or Organ Component]
   861   C0205095:Dorsal [Spatial Concept]
   861   C0504074:Raphe [Body Space or Junction]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.110: In wild-type animals, binding was also abundant in these same regions as well as the arcuate and ventromedial nuclei, areas where ER is concentrated in rat (11). 

Phrase: "In wild-type animals,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003070:Animals, Wild [Animal]
   827   C0003062:Animals [Animal]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "also abundant in these same regions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2346714:Abundant [Qualitative Concept]

Phrase: "as well as"

Phrase: "the arcuate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205130:Arcuate [Spatial Concept]

Phrase: "and"

Phrase: "ventromedial nuclei,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007610:Nucleus [Cell Component]

Phrase: "areas where ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   861   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "concentrated in rat"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0034693:Rat, NOS [Mammal]
   790   C0034721:Rat [Mammal]
   790   C1880165:Concentrated [Biomedical or Dental Material]
   756 E C1880310:Concentrate [Manufactured Object]
   756 E C2003864:Concentrate [Substance]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.111: In an attempt to characterize the nature of the estrogen binding site(s) seen in the ERKO and wild-type brain, animals were treated with an ER selective agonist (16IE2) before the injection of 125I-estrogen. 

Phrase: "In an attempt to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516084:Attempt [Event]

Phrase: "characterize"

Phrase: "the nature of the estrogen binding site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0349590:Nature [Idea or Concept]
   748   C1262865:Nature [Functional Concept]

Phrase: "("

Phrase: "s)"

Phrase: "seen in the ERKO"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   790   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   790   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   753   C0205397:Seen [Qualitative Concept]
   753   C0560617:knock out [Injury or Poisoning]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1522225:Knock-out [Experimental Model of Disease]
   753   C2936882:Estrogen [Pharmacologic Substance]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: "and"

Phrase: "wild-type brain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "treated with an ER selective agonist"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   778   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   778   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1522326:Treated [Functional Concept]
   748   C2936882:Estrogen [Pharmacologic Substance]
   748   C2987634:Agonist [Pharmacologic Substance]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "(16IE2"

Phrase: ")"

Phrase: "before the injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "of 125I-estrogen."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.112: Competition with 16IE2 markedly reduced the distribution of binding sites seen in the wild-type brain and eliminated binding in brain regions where ER is predominantly expressed. 

Phrase: "Competition with 16IE2 markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0679932:competition [Social Behavior]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the distribution of binding sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "seen in the wild-type brain"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0205397:Seen [Qualitative Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1547052:*Type [Quantitative Concept]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: "and"

Phrase: "eliminated binding in brain regions where ER"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C1149369:estrogen receptor binding [Molecular Function]
   767   C0597358:Receptor Binding [Molecular Function]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "predominantly"

Phrase: "expressed."
Processing 00000000.tx.113: The resulting pattern of binding seen in the wild-type brains was similar to that seen in ERKO animals. 

Phrase: "The resulting pattern of binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1523331:pattern binding [Molecular Function]
   760   C0449774:Pattern [Spatial Concept]

Phrase: "seen in the wild-type brains"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0205397:Seen [Qualitative Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   719 E C0042789:see [Organism Function]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]
   719 E C1947903:See [Activity]

Phrase: "was"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "seen in ERKO animals."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   790   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   790   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   773   C1171353:knockout animal [Animal]
   753   C0003062:Animals [Animal]
   753   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   753   C0205397:Seen [Qualitative Concept]
   753   C0560617:knock out [Injury or Poisoning]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1522225:Knock-out [Experimental Model of Disease]
   753   C2936882:Estrogen [Pharmacologic Substance]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]
Processing 00000000.tx.114: In the ERKO mouse brain, 16IE2 slightly attenuated the degree of binding seen in the brain but had no effect on the topography of labeled cells. 

Phrase: "In the ERKO mouse brain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1521713:Mouse Brain [Tissue]
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "16IE2 slightly"

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "the degree of binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "seen in the brain"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0205397:Seen [Qualitative Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "but"

Phrase: "had"

Phrase: "no effect on the topography of labeled cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1301751:No effect [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.115: The attenuation in labeling intensity seen in the ERKO brains was probably due to the amount of compound administered (250 g/kg), a dose that was intended to eliminate ER binding but may have also eliminated some ER binding. 

Phrase: "The attenuation in labeling intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0599946:Attenuation [Activity]

Phrase: "seen in the ERKO brains"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   778   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   778   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0006104:Brains [Body Part, Organ, or Organ Component]
   748   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   748   C0205397:Seen [Qualitative Concept]
   748   C0560617:knock out [Injury or Poisoning]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1522225:Knock-out [Experimental Model of Disease]
   748   C2936882:Estrogen [Pharmacologic Substance]
   714 E C0042789:see [Organism Function]
   714 E C1269537:Brain [Body Part, Organ, or Organ Component]
   714 E C1947903:See [Activity]

Phrase: "was"

Phrase: "probably due to the amount of compound"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0205198:Compound [Qualitative Concept]
   748   C0750492:Probably [Idea or Concept]
   748   C1265611:Amount [Quantitative Concept]
   748   C1706082:Compound [Chemical]
   748   C3146286:Due [Idea or Concept]

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "(250 g/kg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1300563:g/kg [Quantitative Concept]
   827   C0022718:KG [Geographic Area]
   827   C0439209:kg [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "a dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178602:Dose [Quantitative Concept]
  1000   C0869039:Dose [Quantitative Concept]
  1000   C1114758:Dose # [Clinical Attribute]

Phrase: "that"

Phrase: "was"

Phrase: "intended"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1283828:Intended [Qualitative Concept]
  1000   C1551357:intended [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "eliminate"

Phrase: "ER binding"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1149369:estrogen receptor binding [Molecular Function]
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0597358:Receptor Binding [Molecular Function]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0243122:binding [Functional Concept]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "but"

Phrase: "may"

Phrase: "have"

Phrase: "also"

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "some ER binding."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1149369:estrogen receptor binding [Molecular Function]
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0597358:Receptor Binding [Molecular Function]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0243122:binding [Functional Concept]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.116: Additional competition studies showed that all binding in the ERKO and wild-type brains was eliminated with estradiol, but not DHT or R5020, demonstrating that the nuclear concentration of radiolabeled estrogen was specific for an estrogen binding site. 

Phrase: "Additional competition studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0679932:competition [Social Behavior]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "all"

Phrase: "binding in the ERKO"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   820   C1149369:estrogen receptor binding [Molecular Function]
   790   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   790   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   783   C0597358:Receptor Binding [Molecular Function]
   753   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   753   C0243122:binding [Functional Concept]
   753   C0560617:knock out [Injury or Poisoning]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1522225:Knock-out [Experimental Model of Disease]
   753   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "and"

Phrase: "wild-type brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "was"

Phrase: "eliminated with estradiol,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   790   C0849355:Eliminated [Qualitative Concept]
   734 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   734 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "but"

Phrase: "not DHT"

Phrase: "or"

Phrase: "R5020,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878080:R5020 [Hormone,Pharmacologic Substance,Steroid]

Phrase: "demonstrating"

Phrase: "that"

Phrase: "the nuclear concentration of radiolabeled estrogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "specific for an estrogen binding site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0449604:Specific site [Spatial Concept]
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]
Processing 00000000.tx.117: A previous autoradiographic study using MIE2 as a ligand and ERKO mice (18) detected only a few weakly labeled cells in the medial preoptic nucleus, bed nucleus of the stria terminalis, and amygdala after long exposure times (46 weeks). 

Phrase: "A previous autoradiographic study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MIE2 as a ligand"

Phrase: "and"

Phrase: "ERKO mice"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   861   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0206745:Knock-out Mice [Mammal]
   861   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   861   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0560617:knock out [Injury or Poisoning]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1522225:Knock-out [Experimental Model of Disease]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(18"

Phrase: ")"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a few weakly labeled cells in the medial preoptic nucleus,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   741   C0007610:Cell Nucleus [Cell Component]
   739   C0007634:Cells [Cell]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "bed nucleus of the stria terminalis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0228365:Bed Nucleus of Stria Terminalis [Body Part, Organ, or Organ Component]
           Nucleus of Stria Terminalis
           Stria terminalis nucleus
   753   C0004916:Bed [Manufactured Object]
   753   C0007610:Nucleus [Cell Component]
   753   C0596170:BED [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "amygdala after long exposure times"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002708:Amygdala [Body Part, Organ, or Organ Component]

Phrase: "(46 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.118: Although the pattern of distribution was similar to the localization of ER mRNA (13), the degree of binding was markedly attenuated considering the similar level of ER expression in ERKO and wild-type mice. 

Phrase: "Although"

Phrase: "the pattern of distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0449775:Distribution pattern [Spatial Concept]
   770   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "similar to the localization of ER mRNA (13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2348205:Similar [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the degree of binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "the similar level of ER expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C3244092:expression level [Idea or Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "in ERKO"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0560617:knock out [Injury or Poisoning]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1522225:Knock-out [Experimental Model of Disease]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "wild-type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.119: This discrepancy suggested that the radiolabeled estrogen used in these studies (MIE2) had a weak affinity for ER or that the residual binding seen in the ERKO brain was due to the interaction with a splicing variant of ER (15, 18). 

Phrase: "This discrepancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1290905:Discrepancy [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the radiolabeled estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "used in these studies"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   802   C0869040:Use studies [Research Activity]
   770   C0947630:studies [Laboratory Procedure]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]
   737 E C2603343:Study [Research Activity]

Phrase: "(MIE2"

Phrase: ")"

Phrase: "had"

Phrase: "a weak affinity for ER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "that"

Phrase: "the residual binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "seen in the ERKO brain"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   778   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   748   C0205397:Seen [Qualitative Concept]
   748   C0560617:knock out [Injury or Poisoning]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1522225:Knock-out [Experimental Model of Disease]
   748   C2936882:Estrogen [Pharmacologic Substance]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]

Phrase: "was due to the interaction"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1421478:WAS [Gene or Genome]
   760   C1704675:Interaction [Functional Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "with a splicing variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "of ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(15,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.120: Subsequent in vitro binding studies (data not shown) revealed that MIE2 had a higher affinity for ER than for ER, suggesting that the weak labeling seen in the ERKO brain (18) was due to the lower affinity of MIE2 for ER. 

Phrase: "Subsequent in vitro binding studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   872   C0681828:in vitro study [Research Activity]
   804   C0947630:studies [Laboratory Procedure]
   771 E C0557651:Study [Manufactured Object]
   771 E C2603343:Study [Research Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that MIE2"

Phrase: "had"

Phrase: "a higher affinity for ER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "than"

Phrase: "for ER,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the weak labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "seen in the ERKO brain"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   778   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   748   C0205397:Seen [Qualitative Concept]
   748   C0560617:knock out [Injury or Poisoning]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1522225:Knock-out [Experimental Model of Disease]
   748   C2936882:Estrogen [Pharmacologic Substance]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]

Phrase: "(18"

Phrase: ")"

Phrase: "was due to the lower affinity of MIE2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0043194:WAS [Disease or Syndrome]
   744   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0441994:Lower [Spatial Concept]
   744   C1421478:WAS [Gene or Genome]
   744   C1510827:Affinity [Natural Phenomenon or Process]
   744   C1548802:Lower [Body Location or Region]
   744   C2003888:Lower [Activity]
   744   C3146286:Due [Idea or Concept]

Phrase: "for ER."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.121: This hypothesis is supported by the present finding that 16IE2, an ER selective agonist, eliminated binding in regions of the wild-type brain were ER is concentrated (such as the ventromedial and arcuate nuclei), but was unable to eliminate the residual binding seen in regions of the ERKO brain where ER is expressed. 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "supported by the present"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that 16IE2,"

Phrase: "an ER selective agonist,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2987634:Agonist [Pharmacologic Substance]

Phrase: "eliminated binding in regions of the wild-type brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "were"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "concentrated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880165:Concentrated [Biomedical or Dental Material]
   966 E C1880310:Concentrate [Manufactured Object]
   966 E C2003864:Concentrate [Substance]

Phrase: "("

Phrase: "such as the ventromedial"

Phrase: "and"

Phrase: "arcuate nuclei"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0003741:Arcuate Nucleus [Body Part, Organ, or Organ Component]
   861   C0205130:Arcuate [Spatial Concept]
   827   C0007610:Nucleus [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "was"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "eliminate"

Phrase: "the residual binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "seen in regions of the ERKO brain where ER"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   753   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   753   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   751   C1273723:brain regions [Body Location or Region]
   736   C0006104:Brain [Body Part, Organ, or Organ Component]
   736   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   736   C0205397:Seen [Qualitative Concept]
   736   C0560617:knock out [Injury or Poisoning]
   736   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   736   C1269537:Brain [Body Part, Organ, or Organ Component]
   736   C1522225:Knock-out [Experimental Model of Disease]
   736   C2936882:Estrogen [Pharmacologic Substance]
   703   C0017446:Region [Geographic Area]
   703 E C0042789:see [Organism Function]
   703   C0205147:Region [Spatial Concept]
   703 E C1947903:See [Activity]

Phrase: "is"

Phrase: "expressed."
Processing 00000000.tx.122: This finding clearly illustrates that the nuclear uptake and retention of 125I-estrogen in certain regions of the ERKO brain was due to the interaction with ER. 

Phrase: "This finding clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "illustrates"

Phrase: "that"

Phrase: "the nuclear uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "retention of 125I-estrogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035280:Retention [Mental Process]
   770   C0333117:Retention [Functional Concept]
   770   C1753315:retention [Cell Function]

Phrase: "in certain regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "of the ERKO brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "was due to the interaction"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1421478:WAS [Gene or Genome]
   760   C1704675:Interaction [Functional Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "with ER."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.123: However, the results of these studies cannot discount the possibility that an active splicing variant of ER may also exist in the ERKO brain. 

Phrase: "However,"

Phrase: "the results of these studies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results studies [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "cannot"

Phrase: "discount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555671:discount [Intellectual Product]

Phrase: "the possibility"

Phrase: "that"

Phrase: "an active splicing variant of ER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:Variant [Qualitative Concept]

Phrase: "may"

Phrase: "also"

Phrase: "exist in the ERKO brain."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   778   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   748   C0560617:knock out [Injury or Poisoning]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1522225:Knock-out [Experimental Model of Disease]
   748   C2936882:Estrogen [Pharmacologic Substance]
   748   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.124: A recent study by Maffart et al. 

Phrase: "A recent study by Maffart et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]
Processing 00000000.tx.125: (19) has detected very weak ER immunoreactivity in several hypothalamic regions of the ERKO brain including the ventromedial, arcuate, and preoptic nuclei and shown that the treatment of ovariectomized ERKO mice with estrogen increase the number of progesterone receptor immunoreactive cells in these same brain regions. 

Phrase: "(19"

Phrase: ")"

Phrase: "has"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "very weak ER immunoreactivity in several hypothalamic regions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0597879:immunoreactivity [Molecular Function]

Phrase: "of the ERKO brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the ventromedial, arcuate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205130:Arcuate [Spatial Concept]

Phrase: "and"

Phrase: "preoptic nuclei"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033063:Preoptic nuclei [Body Part, Organ, or Organ Component]
   966 E C0599195:preoptic nucleus [Body Part, Organ, or Organ Component]
   827   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the treatment of ovariectomized ERKO mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: "with estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the number of progesterone receptor immunoreactive cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "in these same brain regions."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C1273723:brain regions [Body Location or Region]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.126: Together, these observations suggest that the presence of an active splicing variant of ER in the ERKO brain cannot be discounted at this time. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the presence of an active splicing variant of ER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the ERKO brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "cannot"

Phrase: "be"

Phrase: "discounted at this time."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   737   C1555671:discount [Intellectual Product]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.127: It is also important to realize that the radiolabeled estrogen used in these studies could specifically interact with other proteins, such as additional undiscovered ERs. 

Phrase: "It"

Phrase: "is"

Phrase: "also important to"

Phrase: "realize"

Phrase: "that"

Phrase: "the radiolabeled estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "used in these studies"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   802   C0869040:Use studies [Research Activity]
   770   C0947630:studies [Laboratory Procedure]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]
   737 E C2603343:Study [Research Activity]

Phrase: "could"

Phrase: "specifically"

Phrase: "interact with other proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "such as additional undiscovered ERs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704489:ERS [Clinical Attribute]
   827   C2931783:ERS [Disease or Syndrome]
Processing 00000000.tx.128: Thus, although we feel that the present data demonstrate the presence of ER, which is capable of binding radiolabeled ligand, it is also possible that a portion of the binding seen may represent other yet undiscovered ER(s). 

Phrase: "Thus,"

Phrase: "although"

Phrase: "we"

Phrase: "feel"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013987:feel [Mental Process]
   916 E C1527305:Feeling, NOS [Mental Process]

Phrase: "that"

Phrase: "the present data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "the presence of ER,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "is"

Phrase: "capable of binding radiolabeled ligand,"

Phrase: "it"

Phrase: "is"

Phrase: "also possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "a portion of the binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449719:Portion [Spatial Concept]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "other yet undiscovered ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   861   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "s)."
Processing 00000000.tx.129: A recent in situ hybridization histochemistry study evaluated the anatomical distribution of ER mRNA in the ERKO mouse forebrain (13). 

Phrase: "A recent in situ hybridization histochemistry study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557651:Study [Manufactured Object]
   799   C2603343:Study [Research Activity]

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the anatomical distribution of ER mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]

Phrase: "in the ERKO mouse forebrain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0085140:Fore-Brain [Body Part, Organ, or Organ Component]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.130: The results of that study and the present results found that ER mRNA was abundant in the preoptic area, bed nucleus of the stria terminalis, paraventricular nucleus, amygdala, and dorsal raphe. 

Phrase: "The results of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "that study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "the present results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that ER mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0335218:Messenger [Professional or Occupational Group]

Phrase: "was"

Phrase: "abundant in the preoptic area,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346714:Abundant [Qualitative Concept]

Phrase: "bed nucleus of the stria terminalis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0228365:Bed Nucleus of Stria Terminalis [Body Part, Organ, or Organ Component]
           Nucleus of Stria Terminalis
           Stria terminalis nucleus
   753   C0004916:Bed [Manufactured Object]
   753   C0007610:Nucleus [Cell Component]
   753   C0596170:BED [Mental or Behavioral Dysfunction]

Phrase: "paraventricular nucleus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030532:Paraventricular Nucleus [Body Part, Organ, or Organ Component]
  1000   C1289558:Paraventricular nucleus [Body Location or Region]
   861   C0007610:Nucleus [Cell Component]

Phrase: "amygdala,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002708:Amygdala [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "dorsal raphe."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034671:RAPHE [Body Part, Organ, or Organ Component]
   861   C0205095:Dorsal [Spatial Concept]
   861   C0504074:Raphe [Body Space or Junction]
Processing 00000000.tx.131: Additional hybridization signal was also detected in the suprachiasmatic nucleus, dorsomedial nucleus, medial tuberal nucleus, and entorhinal cortex, whereas only weak signal was seen in the olfactory bulb, septum, cerebral cortex, and Ammons horn of the hippocampus. 

Phrase: "Additional hybridization signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "also"

Phrase: "detected in the suprachiasmatic nucleus,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0038866:Suprachiasmatic Nucleus [Body Part, Organ, or Organ Component]
   806   C1289559:Suprachiasmatic nucleus [Body Location or Region]
   760   C0007610:Nucleus [Cell Component]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "dorsomedial nucleus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0228329:Dorsomedial Nucleus [Body Part, Organ, or Organ Component]
   861   C0007610:Nucleus [Cell Component]

Phrase: "medial tuberal nucleus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "entorhinal cortex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175196:Entorhinal Cortex [Body Part, Organ, or Organ Component]
  1000   C1289526:Entorhinal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "whereas"

Phrase: "only weak signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "seen in the olfactory bulb,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0028936:Olfactory Bulb [Body Part, Organ, or Organ Component]
   806   C1281094:Olfactory bulb [Body Part, Organ, or Organ Component]
   760   C0025148:Bulb [Body Part, Organ, or Organ Component]
   760   C0037361:olfactory [Organism Function]
   760   C0205397:Seen [Qualitative Concept]
   760   C0439826:Olfactory [Organism Function]
   760   C1449865:Bulb [Plant]
   760   C1947952:Bulb [Anatomical Structure]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "septum,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1327729:septum [Cell Component]
  1000   C2362924:Septum [Classification]
   928 E C0442004:Septal [Spatial Concept]

Phrase: "cerebral cortex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "Ammons horn of the hippocampus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0019564:Ammons Horn [Body Part, Organ, or Organ Component]
   760   C0019939:Horn [Body Part, Organ, or Organ Component]
Processing 00000000.tx.132: The present study observed 125I-estrogen binding in many of the same regions. 

Phrase: "The present study observed 125I-estrogen binding in many"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "of the same regions."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.133: In particular, areas such as the preoptic area, bed nucleus of the stria terminalis, paraventricular nucleus, medial amygdala, and dorsal raphe had the highest level of ER mRNA and 125I-estrogen binding, whereas additional regions where the receptor expression was low, had little or no specific binding. 

Phrase: "In particular, areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "such as the preoptic area,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033063:Preoptic Area [Body Part, Organ, or Organ Component]
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: "bed nucleus of the stria terminalis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0228365:Bed Nucleus of Stria Terminalis [Body Part, Organ, or Organ Component]
           Nucleus of Stria Terminalis
           Stria terminalis nucleus
   753   C0004916:Bed [Manufactured Object]
   753   C0007610:Nucleus [Cell Component]
   753   C0596170:BED [Mental or Behavioral Dysfunction]

Phrase: "paraventricular nucleus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030532:Paraventricular Nucleus [Body Part, Organ, or Organ Component]
  1000   C1289558:Paraventricular nucleus [Body Location or Region]
   861   C0007610:Nucleus [Cell Component]

Phrase: "medial amygdala,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0002708:Amygdala [Body Part, Organ, or Organ Component]
   861   C0205098:Medial [Spatial Concept]

Phrase: "and"

Phrase: "dorsal raphe"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034671:RAPHE [Body Part, Organ, or Organ Component]
   861   C0205095:Dorsal [Spatial Concept]
   861   C0504074:Raphe [Body Space or Junction]

Phrase: "had"

Phrase: "the highest level of ER mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "125I-estrogen binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "whereas"

Phrase: "additional regions where"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "the receptor expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597360:receptor expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "low,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "had"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no specific binding."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205369:Specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1552740:specific [Intellectual Product]
Processing 00000000.tx.134: Moreover, an alignment of the receptor localization and estrogen binding sites further indicate that the number of cells, subregional distribution, and topography are in good agreement, suggesting that 125I-estrogen was binding to ER in the ERKO mouse brain. 

Phrase: "Moreover,"

Phrase: "an alignment of the receptor localization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1706765:Alignment [Quantitative Concept]

Phrase: "and"

Phrase: "estrogen binding sites further"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0005456:Binding Sites [Receptor]
   827 E C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Sites [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "indicate"

Phrase: "that"

Phrase: "the number of cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007584:Cell Number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "subregional distribution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "topography"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205627:Topography, NOS [Spatial Concept]
  1000   C0392918:TOPOGRAPHY [Classification]
  1000   C0870781:topography [Spatial Concept]
  1000   C1522605:Topography [Qualitative Concept]

Phrase: "are in good agreement,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205170:Good [Qualitative Concept]
   770   C0680240:Agreement [Social Behavior]
   770   C1551058:Are [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that 125I-estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "binding to ER"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   881   C1149369:estrogen receptor binding [Molecular Function]
   819   C0597358:Receptor Binding [Molecular Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "in the ERKO mouse brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1521713:Mouse Brain [Tissue]
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.135: Together, the present results provide the first evidence that a biologically active ER protein is present in the brain of wild-type and ERKO mice. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the present results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the first evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "a biologically active ER protein"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   884   C0059672:estrogen receptor protein [Amino Acid, Peptide, or Protein,Receptor]
   840   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   840   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   840   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C2936882:Estrogen [Pharmacologic Substance]
   733 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "present in the brain of wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "ERKO mice."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   861   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0206745:Knock-out Mice [Mammal]
   861   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   861   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0560617:knock out [Injury or Poisoning]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1522225:Knock-out [Experimental Model of Disease]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.136: These observations also indicate that estrogen can modulate the expression of genes via ER as well as ER, although other nonreceptor mediated mechanisms are also possible (7, 8). 

Phrase: "These observations also"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "indicate"

Phrase: "that estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "can"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "via ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "as well as"

Phrase: "ER,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "although"

Phrase: "other nonreceptor mediated mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "also possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "(7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.137: Because there are some differences in the distribution of the ERs in the rodent brain (11), it will be important to ascertain which genes are regulated by ER vs. 

Phrase: "Because"

Phrase: "there"

Phrase: "are"

Phrase: "some differences in the distribution of the ERs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "in the rodent brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "will"

Phrase: "be"

Phrase: "important to"

Phrase: "ascertain"

Phrase: "which genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "regulated by ER"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   833   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   833   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "vs."
Processing 00000000.tx.138: ER. 

Phrase: "ER."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.139: In addition, the finding that the two ERs heterodimerize in vitro (20) and are colocalized in neurons of the rat preoptic area, bed nucleus of the stria terminalis, and amygdala (21), further suggests that genes may be differentially regulated by estrogens depending on the ERs present in that particular neuron. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "the two ERs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704489:ERS [Clinical Attribute]
   861   C2931783:ERS [Disease or Syndrome]

Phrase: "heterodimerize"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(20"

Phrase: ")"

Phrase: "and"

Phrase: "are"

Phrase: "colocalized in neurons of the rat preoptic area,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033063:Preoptic Area [Body Part, Organ, or Organ Component]
   744   C0017446:Area [Geographic Area]
   744   C0027882:Neurons [Cell]
   744   C0034693:Rat, NOS [Mammal]
   744   C0034721:Rat [Mammal]
   744   C0205146:Area [Spatial Concept]

Phrase: "bed nucleus of the stria terminalis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0228365:Bed Nucleus of Stria Terminalis [Body Part, Organ, or Organ Component]
           Nucleus of Stria Terminalis
           Stria terminalis nucleus
   753   C0004916:Bed [Manufactured Object]
   753   C0007610:Nucleus [Cell Component]
   753   C0596170:BED [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "amygdala"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002708:Amygdala [Body Part, Organ, or Organ Component]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "may"

Phrase: "be"

Phrase: "differentially"

Phrase: "regulated by estrogens"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   756 E C2936882:Estrogen [Pharmacologic Substance]
   706 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "depending on the ERs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1704489:ERS [Clinical Attribute]
   770   C2931783:ERS [Disease or Syndrome]
   737   C0725813:depend [Medical Device]

Phrase: "present in that particular neuron."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0027882:Neuron [Cell]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
Processing 00000000.tx.140: The discovery of ER and demonstration that it is biologically active in vivo also provides many new insights about estrogen action in the brain. 

Phrase: "The discovery of ER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880355:Discovery [Activity]

Phrase: "and"

Phrase: "demonstration"

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "biologically active in vivo also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1515655:In Vivo [Spatial Concept]
           vivo
   804   C0205177:Active [Functional Concept]
   804   C0205460:Biologically [Qualitative Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "many new insights about estrogen action"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0233820:insights [Mental Process]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.141: Before the discovery of ER, investigators noticed that estrogen regulated many physiological parameters in brain regions that lacked the classical ER. 

Phrase: "Before the discovery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880355:Discovery [Activity]

Phrase: "of ER,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "investigators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035173:Investigators [Professional or Occupational Group]

Phrase: "noticed"

Phrase: "that estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "many physiological parameters in brain regions"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0449381:Parameters [Finding]
   719 E C0549193:Parameter [Spatial Concept]
   719 E C1704769:Parameter [Conceptual Entity]
   719 E C2350001:Parameter [Quantitative Concept]

Phrase: "that"

Phrase: "lacked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0332268:lack [Qualitative Concept]

Phrase: "the classical ER."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.142: In the absence of a nuclear ER, it was thought that these actions were mediated through a putative membrane receptor, activation of second messenger systems, or by way of interneuronal connections (4, 7, 8). 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of a nuclear ER,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   913   C0206588:Nuclear Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "it"

Phrase: "was"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "that"

Phrase: "these actions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441472:actions [Functional Concept]
   966 E C3266814:Action [Activity]

Phrase: "were"

Phrase: "mediated through a putative membrane receptor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0230664:Membrane receptor [Receptor]
   753   C0025255:Membrane [Tissue]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0596901:Membrane [Cell Component]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1706182:Membrane [Manufactured Object]

Phrase: "activation of second messenger systems,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "or by way of interneuronal connections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449379:connections [Intellectual Product]

Phrase: "(4,"

Phrase: "7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.143: For example, it was known that the levels of oxytocin and vasopressin mRNA in the magnocellular neurons of the paraventricular and/or supraoptic nuclei changed over the estrus cycle as well as during pregnancy and lactation (22), even though these regions lacked the classical ER. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "it"

Phrase: "was"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that"

Phrase: "the levels of oxytocin"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "vasopressin mRNA in the magnocellular neurons of the paraventricular"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   739   C0335218:Messenger [Professional or Occupational Group]

Phrase: "and/or"

Phrase: "supraoptic nuclei"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0038869:Supraoptic Nucleus [Body Part, Organ, or Organ Component]
   966   C1289557:Supraoptic nucleus [Body Location or Region]
   827   C0007610:Nucleus [Cell Component]

Phrase: "changed over the estrus cycle"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0014948:Estrus [Organism Function]
   760   C0323166:Estrus [Eukaryote]
   760   C0392747:Changed [Functional Concept]
   760   C0443172:Changed [Quantitative Concept]
   760   C1511572:Cycle [Temporal Concept]
   760   C2959526:Estrus [Finding]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "as well as during pregnancy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0032961:Pregnancy [Organism Function]
   760   C0205170:Well [Qualitative Concept]
   760   C3146287:Well [Manufactured Object]
   760   C3484365:Pregnancy [Clinical Attribute]

Phrase: "and"

Phrase: "lactation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006147:Lactation [Organism Function]
  1000   C0022925:Lactation [Organ or Tissue Function]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "even"

Phrase: "though"

Phrase: "these regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "lacked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0332268:lack [Qualitative Concept]

Phrase: "the classical ER."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.144: The finding that many of these neurons also express ER mRNA (23) and are capable of binding 125I-estrogen (Shughrue, P. J., and I. Merchenthaler, unpublished observations), suggests that estrogen may directly regulate these genes via ER, although this hypothesis has yet to be verified experimentally. 

Phrase: "The finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "many of these neurons also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0027882:Neurons [Cell]
   760   C0439064:Many [Quantitative Concept]
   760   C0747726:many [Conceptual Entity]

Phrase: "express"

Phrase: "ER mRNA (23"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   840   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   840   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   840   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   804   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0335218:Messenger [Professional or Occupational Group]
   804   C0450348:23 [Quantitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C2936882:Estrogen [Pharmacologic Substance]
   733 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "are"

Phrase: "capable of binding 125I-estrogen"

Phrase: "(Shughrue,"

Phrase: "P. J.,"

Phrase: "and"

Phrase: "I. Merchenthaler,"

Phrase: "unpublished observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "may"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "regulate"

Phrase: "these genes via ER,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1335671:Receptor Gene [Gene or Genome]
   760   C0017337:Genes [Gene or Genome]

Phrase: "although"

Phrase: "this hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "has"

Phrase: "yet to"

Phrase: "be"

Phrase: "verified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verified [Functional Concept]

Phrase: "experimentally."
Processing 00000000.tx.145: Perhaps the most intriguing sites of estrogen action are the brain regions associated with learning and memory, where estrogen has been shown to regulate many parameters, including the expression of nerve growth factors and their receptors (24), choline acetyltransferase (24), synaptogenesis, and dendritic arborization (6). 

Phrase: "Perhaps"

Phrase: "the most intriguing sites of estrogen action"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   774   C0581718:action sites [Intellectual Product]
   762   C2945843:Site of [Qualitative Concept]
   748   C0205145:Sites [Spatial Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "the brain regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C1273723:brain regions [Body Location or Region]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "associated with learning"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0013621:learning [Educational Activity]
   790   C0023185:Learning [Mental Process]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "memory,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "where estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "many parameters,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0449381:Parameters [Finding]
   966 E C0549193:Parameter [Spatial Concept]
   966 E C1704769:Parameter [Conceptual Entity]
   966 E C2350001:Parameter [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the expression of nerve growth factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "their receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(24"

Phrase: ")"

Phrase: ","

Phrase: "choline acetyltransferase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008407:Choline Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413376:CHOLINE ACETYLTRANSFERASE [Gene or Genome]
   861   C0001068:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001390:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0008405:Choline [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(24"

Phrase: ")"

Phrase: ","

Phrase: "synaptogenesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597545:synaptogenesis [Organ or Tissue Function]

Phrase: "and"

Phrase: "dendritic arborization"

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.146: The presence of ER in the cortex (13, data reported herein), an area with no ER in the adult rat brain (11), suggests that estrogen may regulate genes in these regions via ER. 

Phrase: "The presence of ER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "(13,"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "herein"

Phrase: ")"

Phrase: ","

Phrase: "an area with no ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Area [Geographic Area]
   753   C0205146:Area [Spatial Concept]

Phrase: "in the adult rat brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "may"

Phrase: "regulate"

Phrase: "genes in these regions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Genes [Gene or Genome]

Phrase: "via ER."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.147: Future studies are clearly needed to elucidate the role of ER in these brain regions and to determine if ER-dependent pathways are involved in the cognitive improvements seen in postmenopausal women taking estrogen replacement therapy (25, 26, 27).  

Phrase: "Future studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "clearly"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elucidate"

Phrase: "the role of ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in these brain regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C1273723:brain regions [Body Location or Region]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "ER-dependent pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]

Phrase: "are"

Phrase: "involved in the cognitive improvements"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1314939:Involved [Functional Concept]
   760   C1516691:Cognitive [Functional Concept]
   726   C2986411:Improvement [Conceptual Entity]

Phrase: "seen in postmenopausal women"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0043210:Women [Population Group]
   770   C0205397:Seen [Qualitative Concept]
   770   C0232970:postmenopausal [Temporal Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "taking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "estrogen replacement therapy"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0014935:Estrogen Replacement Therapy [Therapeutic or Preventive Procedure]
           Estrogen Replacement
   913   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   901   C0086258:Estrogen Replacement [Therapeutic or Preventive Procedure]
   901   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1363945:Therapy [Finding]
   827   C1555302:Replacement [Idea or Concept]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(25,"

Phrase: "26,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.148: Acknowledgments  The authors thank Marlene Blume, Sheau-Mei Cheng, and Heather Harris for their help with the in vitro binding studies and Dr. 

Phrase: "Acknowledgments"

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Marlene Blume,"

Phrase: "Sheau-Mei Cheng,"

Phrase: "and"

Phrase: "Heather Harris for their"

Phrase: "help with the in vitro binding studies"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   788   C0681828:in vitro study [Research Activity]
           studies vitro
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]
   748   C0018896:Help [Social Behavior]
   748   C0243122:binding [Functional Concept]
   748   C0947630:studies [Laboratory Procedure]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1552861:help [Idea or Concept]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.149: Richard Hochberg for providing us with nonisotopic iodinated ligands. 

Phrase: "Richard Hochberg for providing"

Phrase: "us with nonisotopic iodinated ligands."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0023688:Ligands [Chemical]
Processing 00000000.tx.150: Discussions with Dr. 

Phrase: "Discussions with Dr."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0557061:discussions [Therapeutic or Preventive Procedure]
   756 E C2584313:Discussion [Social Behavior]
Processing 00000000.tx.151: Neil MacLusky were also essential for developing the methodology used for these binding assays. 

Phrase: "Neil MacLusky"

Phrase: "were"

Phrase: "also essential for developing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "the methodology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0969625:methodology [Intellectual Product]
  1000   C3266812:Methodology [Idea or Concept]

Phrase: "used for these binding assays."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1273517:used [Finding]
   726   C0005507:Assay [Laboratory Procedure]
   726 E C0042153:use [Functional Concept]
   726   C0243073:assay [Qualitative Concept]
   726 E C0457083:Use [Functional Concept]
   726   C1510438:Assay [Laboratory Procedure]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.152: Received November 19, 1998.  

Phrase: "Received November 19,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "1998."
Processing 00000000.tx.153: References Top Abstract Introduction Materials and Methods Results Discussion References  Drner G 1980 Sexual differentiation of the brain. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Drner G 1980 Sexual differentiation of the brain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0036874:Sexual Differentiation [Organ or Tissue Function]
   744   C0007589:Differentiation [Cell Function]
   744   C1511938:Differentiation [Clinical Attribute]
   744   C2945687:Differentiation [Functional Concept]
Processing 00000000.tx.154: Vitam Horm 38:325381[Medline] Blaustein JD, Olster DH 1989 Gonadal steroid hormone receptors and social behaviors. 

Phrase: "Vitam Horm 38"

Phrase: ":"

Phrase: "325381"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Blaustein JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Olster DH 1989 Gonadal steroid hormone receptors"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   845   C0036884:gonadal steroid hormone [Hormone,Pharmacologic Substance]
   829   C0034840:Receptors, Steroid [Amino Acid, Peptide, or Protein,Receptor]
   829   C0301819:Gonadal hormone [Hormone]
   818   C0019929:hormone receptors [Amino Acid, Peptide, or Protein,Receptor]
   818   C0301818:Steroid hormone [Hormone,Steroid]
   812   C0597519:steroid hormone receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C0019932:Hormone [Hormone]
   795   C0038317:Steroid [Steroid]
   795   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   785 E C1367453:HORMONE RECEPTOR [Gene or Genome]
   724 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "social behaviors."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0037397:Social Behaviors [Social Behavior]
   861   C0004927:Behaviors [Individual Behavior]
   861   C0677505:behaviors [Finding]
   861   C0728831:Social [Functional Concept]
   827 E C2707008:Behavior [Clinical Attribute]
   777 E C2986890:Behavioral [Idea or Concept]
Processing 00000000.tx.155: In: Balthazart J (ed) Advances in comparative environmental physiology. 

Phrase: "In"

Phrase: ":"

Phrase: "Balthazart J (ed)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538926:ED [Idea or Concept]

Phrase: "Advances in comparative environmental physiology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0031844:Physiology, Comparative [Biomedical Occupation or Discipline]
   760   C0014406:Environmental [Spatial Concept]
   760   C0031842:Physiology [Biomedical Occupation or Discipline]
   760   C0031843:physiology [Physiologic Function]
   760   C0725066:Advance [Medical Device]
Processing 00000000.tx.156: Springer-Verlag, Berlin, vol 3:31104 Ogawa S, Taylor JA, Lubahn DB, Korach KS, Pfaff DW 1996 Reversal of sex roles in genetic female mice by disruption of estrogen receptor gene. 

Phrase: "Springer-Verlag,"

Phrase: "Berlin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005125:Berlin [Geographic Area]

Phrase: "vol 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449468:VOL [Quantitative Concept]
   861   C0560268:vol% [Quantitative Concept]
   861   C1690016:% vol [Qualitative Concept]

Phrase: ":"

Phrase: "31104 Ogawa S,"

Phrase: "Taylor JA,"

Phrase: "Lubahn DB,"

Phrase: "Korach KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Pfaff DW 1996 Reversal of sex roles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0443290:Reversal [Functional Concept]

Phrase: "in genetic female mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "by disruption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332453:Disruption [Functional Concept]

Phrase: "of estrogen receptor gene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   734   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.157: Neuroendocrinol 64:467470[Medline] Herbison AE 1998 Multimodal influence of estrogen upon gonadotropin-releasing hormone neurons. 

Phrase: "Neuroendocrinol 64"

Phrase: ":"

Phrase: "467470"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Herbison AE 1998 Multimodal influence of estrogen"

Phrase: "upon gonadotropin-releasing hormone neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0027882:Neurons [Cell]
   756   C0023610:Gonadotrophin releasing hormone [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   729 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.158: Endocr Rev 19:302330[Abstract/Free FullText] Desmond NL, Levy WB 1997 Ovarian steroidal control of connectivity in the female hippocampus: an overview of recent experimental findings and speculations on its functional consequences. 

Phrase: "Endocr Rev 19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "302330"

Phrase: "[Abstract/Free FullText"

Phrase: "] Desmond NL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027778:NL [Geographic Area]
   861   C0560008:nL [Quantitative Concept]

Phrase: "Levy WB 1997 Ovarian steroidal control of connectivity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0243148:control [Qualitative Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]

Phrase: "in the female hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "an overview of recent experimental findings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0814812:overview [Intellectual Product]

Phrase: "and"

Phrase: "speculations on its functional consequences."
Processing 00000000.tx.159: Hippocampus 7:239245[CrossRef][Medline] McEwen BS, Alves SE, Bulloch K, Weiland NG 1997 Ovarian steroids and the brain: implications for cognition and aging. 

Phrase: "Hippocampus 7"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "239245"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McEwen BS,"

Phrase: "Alves SE,"

Phrase: "Bulloch K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Weiland NG 1997 Ovarian steroids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0038317:Steroids [Steroid]

Phrase: "and"

Phrase: "the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "implications for cognition"

Phrase: "and"

Phrase: "aging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]
Processing 00000000.tx.160: Neurology [Suppl 7] 8:S8S15 Kow LM, Mobbs CV, Pfaff DW 1994 Roles of second-messenger systems and neuronal activity in the regulation of lordosis by neurotransmitters, neuropeptides, and estrogen: a review. 

Phrase: "Neurology"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "[Suppl 7"

Phrase: "] 8"

Phrase: ":"

Phrase: "S8S15 Kow LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1261082:LM [Body Part, Organ, or Organ Component]
   827   C1551056:lm [Quantitative Concept]
   827   C2981682:LM [Quantitative Concept]

Phrase: "Mobbs CV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538987:CV [Idea or Concept]

Phrase: "Pfaff DW 1994 Roles of second-messenger systems"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0035820:Roles [Social Behavior]
   711 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "neuronal activity in the regulation of lordosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "by neurotransmitters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027908:Neurotransmitters [Neuroreactive Substance or Biogenic Amine]

Phrase: "neuropeptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027895:Neuropeptides [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "a review."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]
Processing 00000000.tx.161: Neurosci Biobehav Rev 18:251268[CrossRef][Medline] Wehling M 1994 Nongenomic actions of steroid hormones. 

Phrase: "Neurosci Biobehav Rev 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "251268"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wehling M 1994 Nongenomic actions of steroid hormones."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0441472:actions [Functional Concept]
   711 E C3266814:Action [Activity]
Processing 00000000.tx.162: Trends Endocrinol Metab 5:347353 Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J- 1996 Cloning of a novel estrogen receptor expressed in rat prostate and ovary. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Endocrinol Metab 5"

Phrase: ":"

Phrase: "347353 Kuiper GGJM,"

Phrase: "Enmark E,"

Phrase: "Pelto-Huikko M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Nilsson S,"

Phrase: "Gustafsson J- 1996 Cloning of a novel estrogen receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0009015:Cloning [Research Activity]

Phrase: "expressed in rat prostate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1882832:Rat Prostate [Body Part, Organ, or Organ Component]
   770   C0033572:Prostate [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C1278980:Prostate [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ovary."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029939:Ovary [Body Part, Organ, or Organ Component]
  1000   C0227898:ovary [Body Part, Organ, or Organ Component]
  1000   C1278992:Ovary [Body Part, Organ, or Organ Component]
Processing 00000000.tx.163: Proc Natl Acad Sci USA 93:59255930[Abstract/Free FullText] Kuiper GGJM, Shughrue PJ, Merchenthaler I, Gustafsson J- 1998 The estrogen receptors  subtype: a novel mediator of estrogen action in neuroendocrine systems. 

Phrase: "Proc Natl Acad Sci USA 93"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "59255930"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kuiper GGJM,"

Phrase: "Shughrue PJ,"

Phrase: "Merchenthaler I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gustafsson J- 1998"

Phrase: "The estrogen receptors  subtype"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0449560:Subtype [Classification]
   734   C0034804:Estrogen Receptors [Amino Acid, Peptide, or Protein,Receptor]
   701 E C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   701 E C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ":"

Phrase: "a novel mediator of estrogen action"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in neuroendocrine systems."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0027912:Systems, Neuroendocrine [Body System]
           Neuroendocrine
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.164: Front Neuroendocrinol 19:253286[CrossRef][Medline] Shughrue PJ, Lane MV, Merchenthaler I 1997 The comparative distribution of estrogen receptor- and  mRNA in the rat central nervous system. 

Phrase: "Front Neuroendocrinol 19"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205094:front [Spatial Concept]
   755 E C0205123:Frontal [Spatial Concept]
   734 E C0016540:Forehead [Body Location or Region]

Phrase: ":"

Phrase: "253286"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shughrue PJ,"

Phrase: "Lane MV,"

Phrase: "Merchenthaler I 1997"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "The comparative distribution of estrogen receptor-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "mRNA in the rat central nervous system."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C0335218:Messenger [Professional or Occupational Group]
Processing 00000000.tx.165: J Comp Neurol 388:507525[CrossRef][Medline] Hughes A, Larson SM, Hanson RN, DeSombre ER 1997 Uptake and interconversion of the Z and E isomers of 17-iodovinyl-11 methoxyestradiol in the immature female rat. 

Phrase: "J Comp Neurol 388"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0056167:COMP [Therapeutic or Preventive Procedure]
   812   C1456376:COMP [Gene or Genome]

Phrase: ":"

Phrase: "507525"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hughes A,"

Phrase: "Larson SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Hanson RN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540639:RN [Gene or Genome]

Phrase: "DeSombre ER 1997 Uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0243144:Uptake [Physiologic Function]
   804   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "interconversion of the Z"

Phrase: "and"

Phrase: "E isomers of 17-iodovinyl-11 methoxyestradiol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C2984906:E Isomer [Conceptual Entity]
   748   C0022203:isomers [Natural Phenomenon or Process]

Phrase: "in the immature female rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
Processing 00000000.tx.166: Steroids 62:244252[CrossRef][Medline] Shughrue P, Scrimo P, Lane M, Askew R, Merchenthaler I 1997 The distribution of estrogen receptor- mRNA in forebrain regions of the estrogen receptor- knock-out mouse. 

Phrase: "Steroids 62"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038317:Steroids [Steroid]

Phrase: ":"

Phrase: "244252"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shughrue P,"

Phrase: "Scrimo P,"

Phrase: "Lane M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Askew R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Merchenthaler I 1997"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "The distribution of estrogen receptor- mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "in forebrain regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "of the estrogen receptor- knock-out mouse."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   884   C0206745:Knock-Out Mouse [Mammal]
   840   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C0560617:knock out [Injury or Poisoning]
   840   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   840   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C1522225:Knock-out [Experimental Model of Disease]
   804   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   804   C0025914:Mouse [Mammal]
   804   C0025929:mouse [Mammal]
   804   C0026809:Mouse [Mammal]
   804   C0439787:Out [Spatial Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0849355:Out [Qualitative Concept]
   804   C2936882:Estrogen [Pharmacologic Substance]
   733 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.167: Endocrinology 138:56495652[Abstract/Free FullText] Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O 1993 Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. 

Phrase: "Endocrinology 138"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "56495652"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lubahn DB,"

Phrase: "Moyer JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Golding TS,"

Phrase: "Couse JF,"

Phrase: "Korach KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Smithies O 1993 Alteration of reproductive function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1515926:Alteration [Idea or Concept]

Phrase: "but"

Phrase: "not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   750   C0233896:Sexual Development [Organism Function]
   749   C0243101:prenatal development [Functional Concept]
   749   C0678726:Prenatal development [Organism Function]
   735   C0243107:development [Physiologic Function]
   735   C0678723:Development [Organism Function]
   735   C1527148:Development [Functional Concept]
   713   C0017340:Gene, Developmental [Gene or Genome]
Processing 00000000.tx.168: Proc Natl Acad Sci USA 90:1116211166[Abstract] Couse JF, Curtis SW, Washburn TF, Lindzey J, Golding TS, Lubahn DB, Smithies O, Korach KS 1995 Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. 

Phrase: "Proc Natl Acad Sci USA 90"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C0439083:>90 [Quantitative Concept]
   799   C0439087:<90 [Quantitative Concept]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "1116211166"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Couse JF,"

Phrase: "Curtis SW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420193:SW [Gene or Genome]
   861   C1832169:SW [Body System]
   861   C3538902:SW [Gene or Genome]

Phrase: "Washburn TF,"

Phrase: "Lindzey J,"

Phrase: "Golding TS,"

Phrase: "Lubahn DB,"

Phrase: "Smithies O,"

Phrase: "Korach KS 1995 Analysis of transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "estrogen insensitivity in the female mouse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0237677:Insensitivity [Finding]

Phrase: "after targeted disruption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332453:Disruption [Functional Concept]

Phrase: "of the estrogen receptor gene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   734   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.169: Mol Endocrinol 9:14411454[Abstract] Hochberg RB 1979 Iodine- 125-labeled estradiol: a gamma-emitting analog of estradiol that binds to the estrogen receptor. 

Phrase: "Mol Endocrinol 9"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "14411454"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hochberg RB 1979 Iodine- 125-labeled estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   795   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   740 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   740 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: ":"

Phrase: "a gamma-emitting analog of estradiol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0243071:Analog [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "binds to the estrogen receptor."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   806   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   806   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C2936882:Estrogen [Pharmacologic Substance]
Processing 00000000.tx.170: Science 205:11381140[Medline] Brown TJ, Sharma M, Heisler LE, Karsan N, Walters MJ, MacLusky NJ 1995 In vitro labeling of gonadal steroid hormone receptors in brain tissue sections. 

Phrase: "Science 205"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "11381140"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brown TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: "Sharma M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Heisler LE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439090:LE [Idea or Concept]
   861   C1423767:LE [Gene or Genome]

Phrase: "Karsan N,"

Phrase: "Walters MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "MacLusky NJ 1995 In vitro labeling of gonadal steroid hormone receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C1167624:Labeling [Mental Process]
   738   C1947902:Labeling [Manufactured Object]
   738   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "in brain tissue sections."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C2316368:Tissue section [Tissue]
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]
   734   C0440746:Brain tissue [Tissue]
   734   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
Processing 00000000.tx.171: Steroids 60:726737[CrossRef][Medline] Shughrue PJ, Lubahn DB, Negro-Vilar A, Korach KS, Merchenthaler I 1997 Responses in the brain of estrogen receptor -disrupted mice. 

Phrase: "Steroids 60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038317:Steroids [Steroid]

Phrase: ":"

Phrase: "726737"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shughrue PJ,"

Phrase: "Lubahn DB,"

Phrase: "Negro-Vilar A,"

Phrase: "Korach KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Merchenthaler I 1997 Responses in the brain of estrogen receptor -disrupted mice."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   736   C0871261:responses [Organism Attribute]
   703 E C1704632:Response [Finding]
   703 E C1706817:Response [Intellectual Product]
   703 E C2911692:Response [Mental Process]
Processing 00000000.tx.172: Proc Natl Acad Sci USA 94:1100811012[Abstract/Free FullText] Moffatt CA, Rissman EF, Shupnik MA, Blaustein JD 1998 Induction of progesterone receptors by estradiol in the forebrain of estrogen receptor- gene-disrupted mice. 

Phrase: "Proc Natl Acad Sci USA 94"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "1100811012"

Phrase: "[Abstract/Free FullText"

Phrase: "] Moffatt CA,"

Phrase: "Rissman EF,"

Phrase: "Shupnik MA,"

Phrase: "Blaustein JD 1998 Induction of progesterone receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   944 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   944 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "in the forebrain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085140:Fore-Brain [Body Part, Organ, or Organ Component]

Phrase: "of estrogen receptor- gene-disrupted mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.173: J Neurosci 18:95569563[Abstract/Free FullText] Peterson K, Grandien K, Kuiper GGJM, Gustafsson J- 1997 Mouse estrogen receptor -forms estrogen response element binding heterodimers with estrogen receptor . Mol Endocrinol 11:14861496[Abstract/Free FullText] Shughrue PJ, Scrimo PJ, Merchenthaler I 1998 Evidence for the colocalization of estrogen receptor- mRNA and estrogen receptor- in neurons of the rat forebrain. 

Phrase: "J Neurosci 18"

Phrase: ":"

Phrase: "95569563"

Phrase: "[Abstract/Free FullText"

Phrase: "] Peterson K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Grandien K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kuiper GGJM,"

Phrase: "Gustafsson J- 1997 Mouse estrogen receptor -"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   827   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C2936882:Estrogen [Pharmacologic Substance]
   727 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "estrogen response element binding heterodimers with estrogen receptor . Mol Endocrinol 11"

Phrase: ":"

Phrase: "14861496"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shughrue PJ,"

Phrase: "Scrimo PJ,"

Phrase: "Merchenthaler I 1998 Evidence for the colocalization of estrogen receptor- mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   751   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "and"

Phrase: "estrogen receptor-"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "of the rat forebrain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085140:Fore-Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.174: Endocrinology 139:52675270[Abstract/Free FullText] Van Tol HH, Bolwerk EL, Liu B, Burbach JP 1988 Oxytocin and vasopressin gene expression in the hypothalamo-neurohypophyseal system of the rat during the estrous cycle, pregnancy, and lactation. 

Phrase: "Endocrinology 139"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "52675270"

Phrase: "[Abstract/Free FullText"

Phrase: "] Van Tol HH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0062941:HH [Organic Chemical,Pharmacologic Substance]
   827   C1384665:HH [Gene or Genome]
   827   C1414862:Hh [Gene or Genome]

Phrase: "Bolwerk EL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416870:EL [Gene or Genome]
   861   C1823249:EL [Gene or Genome]

Phrase: "Liu B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "Burbach JP 1988 Oxytocin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0030095:Oxytocin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1704206:Oxytocin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   756 E C0733348:Pitocin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "vasopressin gene expression in the hypothalamo-neurohypophyseal system of the rat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0017262:Gene Expression [Genetic Function]
   738   C0017337:Gene [Gene or Genome]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "during the estrous cycle,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0025329:estrous cycle [Organism Function]
  1000   C0950151:Estrous Cycle [Organism Function]
   861   C0014948:estrous [Organism Function]
   861   C1511572:Cycle [Temporal Concept]

Phrase: "pregnancy,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "and"

Phrase: "lactation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006147:Lactation [Organism Function]
  1000   C0022925:Lactation [Organ or Tissue Function]
Processing 00000000.tx.175: Endocrinology 122:945951[Abstract] Hrabovszky E, Kall I, Hajszn T, Shughrue PJ, Merchenthaler I, Liposits Z 1998 Expression of estrogen receptor- messenger ribonucleic acid in oxytocin and vasopressin neurons of the rat supraoptic and paraventricular nuclei. 

Phrase: "Endocrinology 122"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "945951"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hrabovszky E,"

Phrase: "Kall I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Hajszn T,"

Phrase: "Shughrue PJ,"

Phrase: "Merchenthaler I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Liposits Z 1998 Expression of estrogen receptor- messenger ribonucleic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0597360:receptor expression [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in oxytocin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0030095:Oxytocin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704206:Oxytocin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   944 E C0733348:Pitocin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "vasopressin neurons of the rat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]

Phrase: "supraoptic"

Phrase: "and"

Phrase: "paraventricular nuclei."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0175253:Paraventricular nuclei [Body Part, Organ, or Organ Component]
   966 E C0030532:Paraventricular Nucleus [Body Part, Organ, or Organ Component]
   966 E C1289558:Paraventricular nucleus [Body Location or Region]
   827   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.176: Endocrinology 139:26002604[Abstract/Free FullText] Gibbs RB 1994 Estrogen and nerve growth factor-related systems in brain: effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging. 

Phrase: "Endocrinology 139"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "26002604"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gibbs RB 1994 Estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "nerve growth factor-related systems in brain"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   750   C0006104:Nervous System, Brain [Body Part, Organ, or Organ Component]
   750   C0544562:Nervous system factor [Amino Acid, Peptide, or Protein]
   716   C0027763:Systems, Nervous [Body System]
   714   C0449913:System [Functional Concept]
   714   C1553451:System [Manufactured Object]
   714   C1704459:System [Medical Device]
   700 E C0422837:NERVOUS SYSTEM [Finding]
   700 E C1269560:Nervous system [Body System]

Phrase: ":"

Phrase: "effects on basal forebrain cholinergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C3179175:Cholinergic Effects [Physiologic Function]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "implications for learning"

Phrase: "and"

Phrase: "memory processes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0679052:memory process [Mental Process]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "and"

Phrase: "aging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]
Processing 00000000.tx.177: In: Luine VN, Harding CF (eds) Hormonal Restructuring of the Adult Brain: Basic and Clinical Perspectives. 

Phrase: "In"

Phrase: ":"

Phrase: "Luine VN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042658:VN [Geographic Area]
   861   C1336937:VN [Gene or Genome]

Phrase: "Harding CF (eds) Hormonal Restructuring of the Adult Brain"

Phrase: ":"

Phrase: "Basic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527178:Basic [Functional Concept]
   928 E C0920750:basicity [Quantitative Concept]

Phrase: "and"

Phrase: "Clinical Perspectives."
Processing 00000000.tx.178: New York Academy of Sciences, New York, pp 165199 Birge SJ 1996 Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? 

Phrase: "New York Academy of Sciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0000876:Academy [Organization]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "pp 165199 Birge SJ 1996"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1515101:SJ [Geographic Area]
   804   C2986905:SJ [Idea or Concept]

Phrase: "Is"

Phrase: "there"

Phrase: "a role for estrogen replacement therapy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the prevention"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0199176:Prevention [Therapeutic or Preventive Procedure]
  1000   C1706420:PREVENTION [Research Activity]
  1000   C2700409:prevention [Qualitative Concept]

Phrase: "and"

Phrase: "treatment of dementia?"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.179: J Am Geriatr Soc 44:865870[Medline] Birge SJ 1997 The role of estrogen in the treatment of Alzheimers disease? 

Phrase: "J"

Phrase: "Am"

Phrase: "Geriatr Soc 44"

Phrase: ":"

Phrase: "865870"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Birge SJ 1997"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1515101:SJ [Geographic Area]
   827   C2986905:SJ [Idea or Concept]

Phrase: "The role of estrogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of Alzheimers disease?"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.180: Neurology [Suppl 7] 48 S36S41 Wickelgren I 1997 Estrogen stakes claim to cognition. 

Phrase: "Neurology"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "[Suppl 7"

Phrase: "] 48 S36S41 Wickelgren I 1997 Estrogen stakes"

Phrase: "claim to cognition."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0009240:Cognition [Mental Process]
   706 E C2981149:Intellect [Mental Process]
Processing 00000000.tx.181: Science 276:675678[Free FullText]

Phrase: "Science 276"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "675678"

Phrase: "[Free FullText"

Phrase: "]"

